# Chapter 132: Major or Mild Neurocognitive Disorder Due to Huntington’s Disease

## The Biological and Neurological Basis of Neurocognitive Disorder Due to Huntington’s Disease

## Introduction

Major or Mild Neurocognitive Disorder Due to Huntington’s Disease represents the progressive cognitive decline that is a core and devastating feature of Huntington’s Disease (HD), a quintessential monogenic neurodegenerative disorder (Harper, 1996; Kennedy, 2005). HD is inherited in an autosomal dominant fashion, meaning each child of an affected parent has a 50 percent chance of inheriting the disease-causing gene (Stipe et al., 1979; Wilke, 1995; Pani et al., 1993). The disease is characterized by a tragic triad of clinical manifestations: motor disturbances, cognitive decline leading to dementia, and psychiatric disorders (Barboza et al., 2010; Мухин et al., 2010; Lehman & Nance, 2013). While the hyperkinetic motor symptoms, particularly chorea, are the most recognized feature of adult-onset HD, the cognitive and psychiatric disturbances often precede motor signs and contribute significantly to the functional disability associated with the condition (Yeo et al., 2021; Arrojo Romero et al., 2006).

The neurocognitive disorder in HD is a gradually progressive condition, often beginning with mild symptoms that can be difficult to distinguish from normal age-related changes or other psychiatric conditions before escalating to a major neurocognitive impairment (Rowe & Murley, 2023; Puşuroğlu, 2019). This decline encompasses a wide range of cognitive domains, including executive function, memory, attention, and language, ultimately culminating in severe dementia (Мухин et al., 2010; Kořínková, 2006). The biological underpinnings of this cognitive deterioration are rooted in a specific genetic anomaly: an unstable expansion of a cytosine-adenine-guanine (CAG) trinucleotide repeat in the first exon of the huntingtin gene (HTT) on chromosome 4 (Barboza et al., 2010; Harper, 1996; Lehman & Nance, 2013; Gupta & Kushwaha, 2019). This mutation leads to the production of a polyglutamine-expanded huntingtin protein, which is believed to be toxic to neurons (Kořínková, 2006; Devys, 1996).

The neuropathological hallmark of HD is the progressive and selective loss of neurons, most prominently within the striatum (caudate and putamen) of the basal ganglia (Barboza et al., 2010; Woodward, 2009). This striatal atrophy disrupts critical cortico-striato-thalamo-cortical circuits that are essential for motor control, executive function, and emotional regulation, thereby providing a direct anatomical basis for the clinical triad of symptoms (Kořínková, 2006). While historically viewed as a disease of mid-life onset, typically between 30 and 50 years of age (Quarrell, 2020; Stipe et al., 1979), there is increasing evidence that the pathogenic processes may begin much earlier, potentially during fetal development, suggesting HD may have a neurodevelopmental component (Brennand, 2016; Wennagel et al., 2023). This perspective is supported by the distinct clinical presentation of juvenile-onset Huntington's disease (JHD), which manifests before the age of 20 and often presents with rigidity and cognitive failure rather than chorea (Roth, 2012; Lehman & Nance, 2013; Roos, 2009).

This chapter will provide a comprehensive, evidence-based review of the biological and neurological mechanisms that underlie the neurocognitive disorder in Huntington’s Disease. It will explore the genetic and molecular basis of the disease, the specific brain regions and neural circuits affected, the role of neurotransmitter systems, and insights gleaned from neuroimaging. Furthermore, it will examine the disorder from a developmental perspective, considering how early life events and neuroplasticity may influence its trajectory. Finally, it will discuss the biological basis of potential treatments and future directions for research, drawing exclusively on the provided body of scientific literature from the year 2000 to build a cohesive understanding of this complex and devastating illness.

## Neurobiological Systems

The progressive neurodegeneration in Huntington's disease, which drives the development of major or mild neurocognitive disorder, results from widespread dysfunction across multiple integrated neurobiological systems. At the core of the pathology is the disruption of neurotransmitter signaling within specific neural circuits, leading to a cascade of cellular and synaptic failures that manifest as cognitive, motor, and psychiatric symptoms. The primary pathology is centered on the basal ganglia, but its effects ripple throughout the central nervous system (Woodward, 2009).

#### Neurotransmitter Systems and Neuropharmacology

The neurochemical pathology of Huntington's disease is complex, but a central feature is the profound disruption of neurotransmitter systems within the basal ganglia and their connections to the cortex (Kořínková, 2006). The most significantly affected neurons are the GABAergic medium spiny neurons of the striatum (Barboza et al., 2010). The selective loss of these inhibitory neurons is a key event in HD pathogenesis. This leads to a relative overactivity of excitatory neurotransmitter systems, contributing to the characteristic motor and cognitive symptoms (Kořínková, 2006).

The dopaminergic system is also critically implicated, although its role is complex and appears to change over the course of the disease. In adult-onset HD, chorea is often associated with a state of relative dopamine overactivity, which is why dopamine antagonists are sometimes used for symptomatic treatment. Conversely, in juvenile forms of HD, which are often characterized by an akinetic-rigid syndrome rather than chorea, a different state of dopamine function is presumed (Мухин et al., 2010; Roth, 2012). The use of dopamine agonists in some therapeutic approaches for juvenile cases highlights the differential involvement of this system depending on the disease phenotype (Мухин et al., 2010). The complex interplay between GABAergic and dopaminergic systems, along with glutamatergic pathways, creates a profound imbalance in the neural circuits governing movement and cognition. This imbalance is a primary target for pharmacological interventions, which are currently symptomatic and do not alter the disease course (Aubeeluck & Brewer, 2008; Roth, 2012).

#### Brain Regions, Neural Circuits, and Functional Connectivity

The neuropathology of HD is characterized by a distinct pattern of neuronal loss, with the striatum (caudate and putamen) being the most severely affected region (Barboza et al., 2010). This striatal atrophy is a hallmark of the disease and can be visualized using neuroimaging techniques like MRI, which often reveal atrophy of both cortical and subcortical structures (Мухин et al., 2010). The basal ganglia, which include the striatum, are central to the regulation of motor function, but they are also integral components of several parallel cortico-striato-thalamo-cortical loops that subserve cognitive and emotional functions (Woodward, 2009).

One of the most critical circuits for cognitive function is the connection between the caudate nucleus and the prefrontal cortex (Kořínková, 2006). Disruption of this circuit is thought to be a primary driver of the executive dysfunction seen in HD, including problems with planning, cognitive flexibility, and impulse control. The widespread expression of the huntingtin protein throughout the body, and particularly in the brain, suggests that pathology is not strictly confined to the striatum (Sousa & Humbert, 2013). Cortical atrophy is also a prominent feature, especially in later stages, contributing to the global cognitive decline and dementia (Мухин et al., 2010). Functional neuroimaging studies in related neurodegenerative disorders have demonstrated hypoperfusion or hypometabolism in key brain regions like the thalamus and frontal associative areas, which are likely also affected in HD, further disrupting functional connectivity (Jourdier, 2021). The progressive degeneration of these interconnected regions leads to a breakdown in the brain's ability to process information and regulate behavior, which is the fundamental basis of the neurocognitive disorder.

## Genetic and Molecular Basis

Major or Mild Neurocognitive Disorder Due to Huntington’s Disease is a paradigmatic monogenic disorder, meaning it is caused by a mutation in a single gene (Kennedy, 2005; Connor & Ferguson‐Smith, 1988). The disease is inherited in an autosomal dominant pattern with almost complete penetrance, meaning that nearly every individual who inherits the mutated gene will eventually develop the disease (Kořínková, 2006; Wilke, 1995; Pani et al., 1993). While most diseases result from complex interactions between genetic and environmental factors, HD's direct link to a single causative gene provides a clear starting point for understanding its molecular basis (Kennedy, 2005; Weatherall, 2001; Unknown, 2009).

#### The HTT Gene and CAG Trinucleotide Repeat Expansion

The genetic basis of HD was identified in 1993 as an unstable expansion of a CAG (cytosine-adenine-guanine) trinucleotide repeat within the first exon of the huntingtin gene (HTT), located on the short arm of chromosome 4 (Barboza et al., 2010; Harper, 1996; Lehman & Nance, 2013; Gupta & Kushwaha, 2019). This discovery placed HD within a novel class of neurodegenerative disorders caused by dynamic mutations of trinucleotide repeats (Harper, 1996; Huret, 1997; Nelson & Zoghbi, 2006; Epplen & Wieczorek, 2007). In the general population, the number of CAG repeats in the HTT gene is polymorphic, typically ranging from 11 to 34 (Kořínková, 2006; Miziara et al., 2007). Alleles within this range are considered normal and stable.

The number of CAG repeats determines the disease status. Alleles with 36-39 repeats are considered to have reduced penetrance, meaning some individuals with this repeat number may not develop symptoms within a normal lifespan. However, alleles with 40 or more CAG repeats are fully penetrant, and individuals carrying such an expansion will inevitably develop HD if they live long enough (Roth, 2012; Barboza et al., 2010). The length of the CAG repeat expansion is inversely correlated with the age of onset of symptoms; larger expansions are associated with an earlier age of onset (Barboza et al., 2010; Burguera Ameave, 2016). This correlation is a fundamental principle in HD genetics, although it does not predict the exact age of onset or the specific pattern of symptoms for an individual (Dürr et al., 2005). Juvenile-onset forms of HD (JHD), with onset before age 20, are typically associated with very large expansions, often exceeding 60 CAG repeats (Roth, 2012; Burguera Ameave, 2016).

#### Genetic Anticipation and Meiotic Instability

A key feature of trinucleotide repeat disorders, including HD, is the phenomenon of genetic anticipation (Unknown, 2019; Pratiwi, 2022). Anticipation describes the tendency for the disease to appear at an earlier age and/or with increased severity in successive generations of an affected family (Huret, 1997; Yager, 1998). The biological basis for this phenomenon in HD is the meiotic instability of the expanded CAG repeat (Barboza et al., 2010; Huret, 1997). The expanded repeat tract is prone to further expansion during gametogenesis, particularly during spermatogenesis (Devys, 1996). Consequently, paternal transmission of the HD allele is more frequently associated with large increases in repeat number and, therefore, with juvenile-onset cases (Agostinho et al., 2019; Koul, 2007). One study documented a father with 38 CAG repeats having children with 40, 41, and 45 repeats, demonstrating this meiotic instability and the resulting earlier onset and more severe phenotype in the offspring (Barboza et al., 2010). This paternal transmission bias is a well-documented example of genomic imprinting, where the effect of a gene depends on the sex of the parent who transmitted it (Kořínková, 2006; Beukeboom, 1992).

#### The Huntingtin Protein and Molecular Pathogenesis

The HTT gene codes for the huntingtin protein (Htt), a large protein that is ubiquitously expressed in various tissues throughout the body, with particularly high levels in the brain (Brandão et al., 2022; Sousa & Humbert, 2013). The normal function of Htt is not fully understood, but it is believed to be involved in numerous crucial cellular processes, including transcriptional regulation, vesicle transport, and anti-apoptotic functions (Kořínková, 2006).

The CAG repeat expansion results in an elongated polyglutamine (polyQ) tract at the N-terminal end of the Htt protein (Devys, 1996). This mutant huntingtin (mHtt) protein is prone to misfolding and aggregation, forming intracellular inclusions that are a pathological hallmark of the disease (Epplen & Wieczorek, 2007). The polyQ expansion confers a toxic gain-of-function on the protein, disrupting numerous cellular pathways and ultimately leading to neuronal dysfunction and death (Zanoteli et al., 2019; Maelicke, 2000). The selective vulnerability of striatal neurons, despite the widespread expression of mHtt, remains a central and unresolved question in HD research (Barboza et al., 2010). It is hypothesized that the pathogenesis involves a complex interplay of excitotoxicity, mitochondrial dysfunction, impaired protein clearance, and transcriptional dysregulation, all triggered by the presence of the mHtt protein (Kořínková, 2006; Sarzi & Rötig, 2010). The identification of genes that contribute to HD through machine learning approaches suggests a complex network of genetic interactions beyond the primary HTT mutation (Cheng et al., 2020).

## Brain Structure and Function

The neurocognitive disorder in Huntington's disease is a direct consequence of progressive, patterned changes in brain structure and function. While the pathology is widespread, it exhibits a characteristic topography that begins in specific subcortical regions and gradually extends to the cerebral cortex. Modern neuroimaging techniques, both structural and functional, have been instrumental in delineating these changes in living patients and correlating them with clinical symptoms.

#### Neuroanatomical and Structural Neuroimaging Findings

The cardinal neuroanatomical feature of Huntington's disease is the profound and progressive atrophy of the basal ganglia, particularly the striatum (caudate nucleus and putamen) (Woodward, 2009). This degeneration is primarily due to the selective loss of GABAergic medium spiny neurons (Barboza et al., 2010; Kořínková, 2006). This striatal atrophy is often the most conspicuous finding on structural neuroimaging. Magnetic Resonance Imaging (MRI) studies consistently reveal a reduction in the volume of the caudate and putamen, which can be detected even in presymptomatic gene carriers (Dürr et al., 2005).

In addition to the striatum, MRI scans in symptomatic individuals, including those with juvenile-onset forms, show more widespread atrophy affecting the cerebral cortex and other subcortical structures (Мухин et al., 2010). This cortical thinning contributes significantly to the global cognitive decline and dementia that characterize the later stages of the disease (Мухин et al., 2010; Lehman & Nance, 2013). While chorea is often the most prominent motor symptom in adults, the juvenile form of HD frequently presents with hypokinesia and rigidity, a phenotype known as the Westphal variant (Roth, 2012; Roos, 2009). This clinical heterogeneity suggests that the precise pattern and progression of neurodegeneration may vary, potentially influenced by factors such as the size of the CAG repeat expansion and age of onset (Kořínková, 2006). The structural changes observed on MRI provide a clear biological substrate for the devastating clinical manifestations of the disease (Sarmento et al., 2023).

#### Functional Neuroimaging and Neural Circuit Disruption

While structural imaging reveals the anatomical consequences of neuronal loss, functional neuroimaging techniques offer insights into the physiological dysfunction of neural circuits that precedes and accompanies these structural changes. The pathology in HD is not merely a matter of cell loss in isolated regions but a disruption of large-scale brain networks (Kořínková, 2006). Functional neuroimaging studies in related neurodegenerative conditions have shown hypometabolism and hypoperfusion in key cortical and subcortical areas, including the thalamus and frontotemporal regions, which are critical nodes in cognitive and motor circuits (Jourdier, 2021). Similar disruptions are central to the pathophysiology of HD.

The cortico-striatal-thalamic loops are particularly vulnerable. The loss of inhibitory output from the striatum leads to dysregulation of thalamic and cortical activity, contributing to both motor and non-motor symptoms (Kořínková, 2006). The connection between the caudate nucleus and the prefrontal cortex is crucial for executive functions, and its disruption is a key mechanism underlying the cognitive deficits in HD (Kořínková, 2006). Studies on electroencephalography (EEG) in patients with JHD have demonstrated a marked slowing of background activity, reflecting diffuse cerebral dysfunction that correlates with the regression of mental functions (Мухин et al., 2010). Furthermore, epileptic seizures and myoclonus are frequent manifestations in JHD, indicating a state of cortical hyperexcitability that can also be detected with EEG (Roth, 2012; de Saint Martin, 2001). These functional abnormalities highlight that HD is a disease of brain circuits, where the genetic mutation initiates a cascade of events leading to widespread functional and, ultimately, structural disintegration of the brain.

## Developmental Neurobiology

Traditionally conceptualized as an adult-onset neurodegenerative disorder, a growing body of evidence suggests that Huntington's disease has significant neurodevelopmental origins. This perspective posits that the pathogenic processes initiated by the mutant huntingtin (mHtt) protein do not begin abruptly in mid-life but rather subtly disrupt brain development from its earliest stages, creating a vulnerability that manifests clinically decades later (Brennand, 2016; Wennagel et al., 2023). This developmental framework helps to explain some of the disease's complexities, including the variable age of onset and the distinct phenotypes observed in juvenile versus adult cases.

#### Early Onset and Neurodevelopmental Abnormalities

The concept of HD as a neurodevelopmental disorder is strongly supported by studies of patient-derived neural stem cells (Brennand, 2016). Gene expression analyses have revealed that pathogenic processes may be initiated during fetal development, long before the onset of clinical symptoms (Brennand, 2016). The HTT gene is expressed throughout the body, including during embryogenesis, suggesting that the mHtt protein can influence neural proliferation, migration, and differentiation (Sousa & Humbert, 2013; Stavljenić-Rukavina et al., 2009). While gross structural malformations of the brain are not typical in HD, subtle alterations in neuronal maturation and circuit formation may occur (Weller et al., 1983; Saliba, 2018). These early, subclinical disruptions could compromise the brain's resilience, making it more susceptible to the cumulative toxic effects of mHtt over a lifetime (Jones, 2002; Cannon & Murray, 1998).

This model is further supported by research in animal models, which demonstrates that treating transient, early neuronal defects can prevent the emergence of adult-onset symptoms (Wennagel et al., 2023). This finding implies that there may be a critical period during development where the trajectory towards neurodegeneration could be altered. Clinical observations in juvenile Huntington's disease (JHD) also align with a neurodevelopmental hypothesis. Children with JHD, who carry very large CAG expansions, often present with symptoms that overlap with other neurodevelopmental disorders, such as intellectual disability, learning difficulties, and speech and language delay (Lehman & Nance, 2013; Yoon et al., 2006; Roth, 2012). Speech delay, for instance, can be one of the very first manifestations of JHD, predating motor symptoms by several years (Yoon et al., 2006). This contrasts sharply with the classic adult-onset presentation dominated by chorea, suggesting that the timing of the pathogenic insult during brain development profoundly influences the clinical phenotype (Roos, 2009; Thiels et al., 2020).

#### Biological Subtypes and Heterogeneity

The clinical presentation of HD is remarkably heterogeneous, varying in age of onset, initial symptoms, and rate of progression (Kořínková, 2006; Weatherall, 2001). This variability is most pronounced when comparing adult-onset HD with JHD. Adult-onset HD typically begins between ages 30 and 50 and is characterized by chorea, psychiatric changes, and a gradual cognitive decline (Quarrell, 2020; Stipe et al., 1979). In contrast, JHD, which accounts for about 5-10% of cases with onset before age 20, often presents with a rigid-dystonic picture, seizures, and severe, rapidly progressing cognitive impairment (Lehman & Nance, 2013; Aubeeluck & Brewer, 2008; Roth, 2012). Epilepsy, which is very rare in adult HD, is observed in approximately one-third of juvenile patients (Thiels et al., 2020; de Saint Martin, 2001).

This phenotypic divergence can be largely, though not entirely, explained by the underlying genetics. JHD is almost always associated with large CAG repeat expansions (often >60), which are typically inherited from the father due to meiotic instability during spermatogenesis (Roth, 2012; Agostinho et al., 2019). The larger the repeat number, the earlier the onset and often the more severe the course of the disease (Barboza et al., 2010; Burguera Ameave, 2016). The rigid-akinetic "Westphal variant" is a classic manifestation in JHD but can also be seen at any age (Roos, 2009; Sarmento et al., 2023). The different clinical pictures suggest that the massive expression of a highly toxic mHtt protein during critical periods of brain maturation in JHD may lead to a different pattern of neurodegeneration than the more insidious process seen in adult-onset disease (Brennand, 2016). While the CAG repeat length is the primary determinant of age of onset, other genetic and possibly environmental factors are thought to modify the disease course and contribute to the remaining clinical heterogeneity (Weatherall, 2001; Connor & Ferguson‐Smith, 1988).

## Treatment Mechanisms

Currently, there is no cure for Huntington's disease, and no treatments have been proven to slow or stop the relentless neurodegenerative process (Woodward, 2009; Aubeeluck & Brewer, 2008). The management of Major or Mild Neurocognitive Disorder Due to Huntington’s Disease, along with its associated motor and psychiatric symptoms, is therefore palliative and focuses on symptomatic relief to improve quality of life (Woodward, 2009). The biological basis of current interventions is aimed at correcting the neurochemical imbalances that result from the underlying neuropathology, rather than targeting the root genetic cause.

#### Symptomatic Pharmacotherapy

Pharmacological strategies are tailored to the specific symptoms manifested by the patient, which can vary significantly between individuals and across the disease course (Roth, 2012). The neurochemical disruptions, particularly within the basal ganglia circuits, are the primary targets of these interventions. In adult-onset HD where chorea is prominent, the underlying pathophysiology is often conceptualized as a state of relative dopaminergic hyperactivity resulting from the degeneration of GABAergic striatal neurons (Kořínková, 2006). Consequently, treatments for chorea often involve dopamine-depleting agents or dopamine receptor antagonists.

Conversely, the management of juvenile Huntington's disease (JHD), which frequently presents with an akinetic-rigid syndrome, may involve different strategies. The observation that some JHD patients have been treated with dopamine agonists suggests a different neurochemical state, possibly reflecting a more parkinsonian-like pathophysiology in this subgroup (Мухин et al., 2010). Psychiatric symptoms, such as depression, anxiety, and psychosis, are common and can precede motor onset (Yeo et al., 2021; Arrojo Romero et al., 2006). These are managed with standard psychiatric medications, such as antidepressants and antipsychotics, which act on serotonergic, dopaminergic, and other neurotransmitter systems (Hesse, 1986). However, all current pharmacological treatments are considered "off-label" for JHD, as no specific evidence-based guidelines exist for this rare population (Roth, 2012). The cognitive decline itself has proven particularly refractory to pharmacological intervention, and nootropic drugs have not shown significant benefit (Мухин et al., 2010).

#### Neuroplasticity, Compensatory Mechanisms, and Future Implications

Despite the progressive nature of the disease, the brain is not a passive victim of neurodegeneration. The concept of neuroplasticity suggests that the brain attempts to compensate for neuronal loss and circuit disruption. However, the capacity for such compensation is limited and eventually overwhelmed by the disease process. The long presymptomatic phase of HD, during which individuals with the gene mutation are clinically normal despite ongoing neuropathology, is evidence of the brain's remarkable compensatory ability (Dürr et al., 2005).

The emerging understanding of HD as a neurodevelopmental disorder has profound implications for future treatment strategies (Brennand, 2016). If pathogenic processes begin in utero and disrupt early brain development, interventions may need to be initiated far earlier than is currently practiced, potentially even prenatally or in early childhood, to be effective. A landmark study in a mouse model of HD demonstrated that correcting transient neuronal defects early in development could prevent the later onset of adult symptoms (Wennagel et al., 2023). This finding provides a compelling biological rationale for developing therapies aimed at early intervention. Future treatments may focus on supporting neurodevelopment, enhancing neuroplasticity, or targeting the very initial molecular events triggered by mutant huntingtin, long before widespread cell death occurs (Wennagel et al., 2023). Genetic therapies, aimed at lowering the levels of the toxic mutant huntingtin protein, are also under investigation and represent the most direct approach to tackling the root cause of the disease (Cheng et al., 2020). The ultimate goal is to move from purely symptomatic management to disease-modifying therapies that can alter the natural history of this devastating disorder.

## Future Directions

The understanding of the biological basis of Huntington's disease has advanced dramatically since the discovery of the HTT gene, yet significant challenges and unanswered questions remain (Harper, 1996). Future research must focus on translating the wealth of genetic and molecular knowledge into effective therapeutic strategies that can halt or reverse the neurodegenerative process. The field is moving towards a more nuanced view of HD, recognizing its developmental origins and the complexity of its downstream pathology.

A primary area of ongoing research is the elucidation of the precise functions of the normal huntingtin protein and the specific mechanisms by which the mutant form exerts its toxicity (Sousa & Humbert, 2013). While the polyglutamine expansion is the clear initiator, the subsequent cascade of cellular dysfunction—involving mitochondrial impairment, transcriptional dysregulation, and impaired protein clearance—is multifaceted (Kořínková, 2006; Sarzi & Rötig, 2010). Understanding why striatal neurons are selectively vulnerable despite the ubiquitous expression of mutant huntingtin remains a critical question (Barboza et al., 2010). Identifying modifier genes and environmental factors that influence the age of onset and disease progression, independent of the primary CAG repeat length, is another key goal that could reveal novel therapeutic targets (Weatherall, 2001; Connor & Ferguson‐Smith, 1988).

The conceptual shift towards viewing HD as a neurodevelopmental disorder opens up new avenues for prevention and treatment (Brennand, 2016). The finding that correcting early, transient neuronal deficits in a mouse model can prevent adult symptom onset is particularly promising and underscores the need for biomarkers that can detect these early changes in humans (Wennagel et al., 2023). Research is needed to identify these critical developmental windows and to develop interventions that can be safely administered in presymptomatic individuals, perhaps even in childhood for those at high genetic risk. This approach represents a paradigm shift from treating established neurodegeneration to preserving neurological health from the earliest stages of life.

The development of therapies that directly target the HTT gene or its protein product is the most anticipated frontier. Strategies such as antisense oligonucleotides, RNA interference, and gene editing aim to lower the production of the toxic mutant huntingtin protein. As these genetic therapies move into clinical trials, critical questions regarding their long-term safety, efficacy, and optimal delivery to the brain must be addressed. Furthermore, the psychosocial and ethical dimensions of presymptomatic and prenatal genetic testing will continue to evolve alongside these technological advances (Dürr et al., 2005; Gargiulo & Dürr, 2018; Lesca, 2002). The ability to predict an individual's genetic status for an incurable disease raises profound challenges for individuals and families, necessitating robust multidisciplinary support systems (De Luca & Gargiulo, 2019; Gargiulo & Dürr, 2018). Ultimately, a combination of genetic therapies to address the root cause and neuroprotective strategies to support neuronal function will likely be required to conquer this devastating disorder.

## Conclusion

Major or Mild Neurocognitive Disorder Due to Huntington’s Disease is the cognitive manifestation of a complex, inherited neurodegenerative condition rooted in a single, well-defined genetic mutation (Harper, 1996; Barboza et al., 2010). The expansion of a CAG trinucleotide repeat in the HTT gene initiates a cascade of molecular and cellular events that culminate in the progressive loss of neurons, primarily within the striatum and cerebral cortex (Barboza et al., 2010; Мухин et al., 2010). This neuropathology directly disrupts the cortico-striato-thalamic circuits that are fundamental to motor control, cognitive processing, and emotional regulation, providing a clear biological basis for the disease's characteristic triad of symptoms (Kořínková, 2006; Woodward, 2009).

The clinical expression of HD is highly variable, a heterogeneity largely driven by the size of the inherited CAG expansion, which is inversely correlated with the age of onset (Burguera Ameave, 2016). This genetic instability gives rise to the phenomenon of anticipation and results in distinct clinical subtypes, most notably the classic adult-onset form and the more severe, rigid-akinetic juvenile-onset form (Unknown, 2019; Roth, 2012; Roos, 2009). A critical evolution in the scientific understanding of HD is the recognition of its neurodevelopmental component (Brennand, 2016). Evidence from cellular and animal models suggests that the pathogenic process does not begin in adulthood but rather subtly perturbs the formation and maturation of the central nervous system from the earliest stages of development (Wennagel et al., 2023). This developmental perspective reframes HD not just as a disease of degeneration, but as a lifelong condition where early developmental abnormalities create a vulnerability that is later unmasked as progressive neuronal loss.

Currently, treatment remains symptomatic, aimed at managing the neurochemical imbalances that arise from the disease process, but without altering its inexorable course (Aubeeluck & Brewer, 2008). However, the deepening understanding of HD's genetic and developmental basis is paving the way for novel therapeutic strategies. The prospect of intervening during a critical developmental window to prevent or delay symptom onset, coupled with the advancement of genetic therapies designed to lower the toxic mutant huntingtin protein, offers unprecedented hope. The journey from gene discovery to a definitive cure is long and fraught with challenges, but the convergence of genetics, developmental neurobiology, and clinical neuroscience continues to illuminate the path forward in the fight against Huntington's disease.

## References

1. Abath, C. B., Gupta, N., Hadjinicolaou, A., Donatelli, S., Singh, A., Merchant, S., Ryan, M. E., Soby, M., Ryan, C. M., Nelson, A. K., Pacheco, J. E. M., Zhang, B., Williams, D. N., Yuskaitis, C. J., & Harini, C. (2023). Delays to care in infantile epileptic spasms syndrome: Racial and ethnic inequities. Epilepsia. https://doi.org/10.1111/epi.17827
2. Acosta-Aragón, M. A., Arias-Linthon, S., & Tobar-Solarte, J. C. (2020). Síndrome CHARGE: reporte de caso. Medicina y Laboratorio. https://doi.org/10.36384/01232576.356
3. Aden, P., Gjerstad, A. C., Skari, H., Lie, A., & Bjerre, A. (2020). Nevrogene blæreforstyrrelser hos barn. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.18.0347
4. Agostinho, L. D. A., Felipe, V. L., da, S. V. C., Thays, A., Silva, G. M. D., Spitz, M., & Paiva, C. L. A. (2019). Juvenile Huntington' Disease: A Case of Paternal Transmission with an Uncommon CAG Expansion. Clinical Medical Reviews and Case Reports. https://doi.org/10.23937/2378-3656/1410253
5. Aguiar, P. D. C., & Ferraz, H. B. (2019). Genética das Distonias. Revista Neurociências. https://doi.org/10.34024/rnc.2000.v8.8946
6. Akinola, I. J., Akinyosoye, G., Ademokoya, O., & Okoro, B. (2022). Occurrence of Type 1 Diabetes Mellitus Two Years after Diagnosis of Graves’Disease in A Child. International Academic Research Journal of Internal Medicine and Public Health. https://doi.org/10.47310/iarjimph.2022.v03i03.006
7. Al-Alawi, A. M., Al-Tawil, K. I., Al-Hathal, M., & Amir, I. (2001). Sporadic neonatal schizencephaly associated with brain calcification. Annals of Tropical Paediatrics. https://doi.org/10.1080/02724930124793
8. Alawi, I. A., Salmi, I. A., Rahbi, F. A., Riyami, M. A., Kalbani, N. A., Ghaithi, B. A., Al‐Mawali, A., & Sayer, J. A. (2019). Molecular Genetic Diagnosis of Omani Patients With Inherited Cystic Kidney Disease. Kidney International Reports. https://doi.org/10.1016/j.ekir.2019.08.012
9. Alberto, M. V. L., Galdos, A. C. R., Miglino, M. A., & Santos, J. M. D. (2001). Anencefalia. Revista Neurociências. https://doi.org/10.34024/rnc.2010.v18.8487
10. Albuquerque, D. S. D., Reyes, N. K. S., Mendonça, T. M. D. O., Dias, C. M., Filho, E. M. D. S., & Cordeiro, J. D. S. (2020). Um Modelo para a Transmissão Vertical da Hanseníase. Proceeding Series of the Brazilian Society of Computational and Applied Mathematics.
11. Aldea, C., Munteanu, T., Delean, D., Bulată, B., Bungardi, A., Man, S. C., Gafencu, M., & Duicu, C. (2018). Sindromul nefrotic infantil – provocări de diagnostic şi management. Romanian Journal of Pediatrics. https://doi.org/10.37897/rjp.2018.1.8
12. Almeida, B. C. P. D., Lima, L. P., Dias, J. P. G., & Júnior, H. S. D. F. (2023). Sífilis gestacional: epidemiologia, patogênese e manejo. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e13861.2023
13. Almira, M. C., Morejón, A. E. G., & Ricardo, G. S. (2016). Síndrome de Bland-White-Garland.
14. Alves, M. P., Peixoto, C. L. L., Leite, A. K. R. D. M., Aquino-Cortez, A., Bezerra, B. M. O., Lima, F. E. D. S., & Guedes, R. F. D. M. (2022). DEMODICIOSE E ESCABIOSE: UM ESTUD EPIDEMIOLÓGICO E CLÍNICO EM UM CLÍNICA VETERINÁRIA NA CIDADE DE FORTALEZA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-15-3-14
15. Alves, R., Freitas, I. C. M. D., Santos, I. C., Afonso, A., & Cardoso, J. (2016). NECROSE GORDA DO RECÉM-NASCIDO. Journal of the Portuguese Society of Dermatology and Venereology. https://doi.org/10.29021/spdv.69.1.640
16. Ameave, L. B. (2016). Diagnóstico genético en menores: el caso de la enfermedad Huntington. DS : Derecho y salud.
17. Andrade, L. A. F. D. (1996). Considerações a respeito da doença de Parkinson de início precoce revisão crítica da literatura. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x1996000400024
18. Angelova, S. (2018). Clinical Manifestation Of The Carious Process In Children Between 0 And 5 Years Of Age Diagnosed With Nephrotic Syndrome. Varna Medical Forum. https://doi.org/10.14748/vmf.v7i0.6082
19. Angle, B., Hersh, J. H., Yen, F., & Verdi, G. D. (1997). XY gonadal dysgenesis associated with a multiple pterygium syndrome phenotype. American Journal of Medical Genetics. https://doi.org/10.1002/(sici)1096-8628(19970110)68:1<7::aid-ajmg2>3.0.co;2-p
20. Anthuber, S., & Anthuber, C. (2013). Endokrinologie. Störungen der Geschlechtsentwicklung aus kindergynäkologischer Sicht. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-0033-1350979
21. Aoyagi, A. M., Silva, I. F. D., Martins, A. D. A., Ribeiro, C. D. L. L., Vieira, Y. D. A., Cardoso, L. C., Domingues, M. M., Branco, A. L. G. C., Silva, A. L. D., Miguel, G. C. D. A., Reisdorfer, V. C., Bogaski, L. R. S., Castro, V. L. P. D., Arenzon, B. E., & Nunes, C. C. D. A. (2023). Síndrome de Peters: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-172
22. Apine, A. (2019). Älterwerden ist unvermeidbar, Erwachsenwerden ist optional – oder warum die Diagnosen des Kindesalters sich nicht an die Regeln halten. Pneumologie. https://doi.org/10.1055/s-0039-1678217
23. Araújo, I. C. T. D., Fonseca, F. L., Dias, J. H. A., Netto, L. A. V., Guimaraes, C. V., Ferreira, L. B., Silva, L. C., Carneiro, A. G. R., Smaniotto, V., Costacurta, E. P., Azevedo, G. C. D., Sousa, R. R. M. D., Freitas, L. V. S., Vieira, A. C. M., Eserian, A. L. D., Araújo, V. B. D., Rangel, I. D. O., Amaral, H. E. F., Silva, I. H. S. D., & Júnior, C. R. D. A. M. (2023). Síndrome de Wilson-Turner: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-239
24. Araújo, I. M. M., Figueiredo, A. F. C., Silva, J. L. N. D., Souza, É. J. L. D., Fernandes, R. B., Freitas, B. K. D. N., Alves, C. I. S., & Magalhães, K. D. (2018). ENCEFALOPATIA CRÔNICA NÃO PROGRESSIVA DA INFÂNCIA CORRELACIONADA A DOENÇA METABÓLICA E SÍNDROME DE WEST: RELATO DE CASO. CADERNOS DE EDUCAÇÃO SAÚDE E FISIOTERAPIA.
25. Arellano, K. R. I., Monjaráz, E. M. T., Barrios, E. M., Zárate‐Mondragón, F., León, J. F. C., Bustamente, R. C., Michel-Penichet, F., Camid, M. D. L. Á. E. G., Quiroga, U. L., García, C. I. O., Nieto, C. M., Alcaráz, M. R., Jasso, K. A. S., Morán, J., Sierra, A. S., Ortiz, S. V., Rubio, R. G., Gómez, O. J. M., & Ramı́rez-Mayans, J. (2018). Diagnóstico y tratamiento de los trastornos gastrointestinales del eje cerebro-intestino en niños menores de 2 años. Acta Pediátrica de México. https://doi.org/10.18233/apm39no6pp376-3841736
26. Arslan-Kirchner, M. (2001). Genetische Aspekte bei Lippen-Kiefer-Gaumenspalten. Sprache · Stimme · Gehör. https://doi.org/10.1055/s-2001-14689
27. Asadi, S., Amjadi, H., Valizadeh, G., & Aranian, M. (2019). None. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.1.1
28. Aubeeluck, A., & Brewer, H. (2008). Huntington’s disease. Part 2: treatment and management issues in juvenile HD. British Journal of Nursing. https://doi.org/10.12968/bjon.2008.17.4.28715
29. Avolio, G. P., Silva, P. S. D., Botelho, A. C. B., Fontoura, A., Santana, J., Canellas, M., Carvalho, K. P. D. S., & Martins, S. R. (2018). CONDUTA FISIOTERAPÊUTICA NO DESENVOLVIMENTO PSICOMOTOR EM CRIANÇA COM SÍNDROME DE DOWN. Antonella Carvalho de Oliveira eBooks. https://doi.org/10.22533/at.ed.90118021230
30. Ayyad, A., Messaoudi, S., & Amrani, R. (2019). Gangrène congénitale entité rare en néonatalogie: à propos d'une observation. Pan African Medical Journal. https://doi.org/10.11604/pamj.2019.33.59.16710
31. Az-Zahra, D. R., Sopiah, P., & Ridwan, H. (2023). KORELASI ANTARA KELAINAN KONGENITAL DENGAN VIRUS RUBELLA PADA IBU HAMIL. Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing). https://doi.org/10.33023/jikep.v9i2.1485
32. Bagautdinova, J., Mayeli, A., Wilson, J., Donati, F., Colacot, R. M., Meyer, N., Fusar‐Poli, P., & Ferrarelli, F. (2023). Sleep Abnormalities in Different Clinical Stages of Psychosis. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2022.4599
33. Bai, R., Haverfield, E., Higgs, J., Suchy, S. F., Arjona, D., Retterer, K., Smaoui, N., Richard, G., Bale, S. J., Kendall, F., Parikh, S., Gropman, A., Haas, R., Goldstein, A., Panzer, J. A., Yum, S. W., Falk, M. J., Saneto, R. P., Enns, G. M., & Chung, W. K. (2013). First-line genetic testing for mitochondrial disorders in the next-generation sequencing era: Comprehensive known disease gene panel or exome sequencing?. Mitochondrion. https://doi.org/10.1016/j.mito.2013.07.092
34. Baldaçara, L., Nóbrega, L. P. C., Tengan, S. K., & Maia, A. K. S. N. (2006). Hiperlexia em um caso de autismo e suas hipóteses. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832006000500007
35. Barazesh, S. (2009). The genetic dimension of height and health: It may be no tall tale: A few inches taller or shorter could signal a risk for some diseases. Science News. https://doi.org/10.1002/scin.2009.5591751018
36. Barber, T. M., & Wass, J. (2020). Hormonal manifestations of nonendocrine disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0261
37. Barboza, H. N., Silva, A. F. A. D., Machado, F. B., & Medina‐Acosta, E. (2010). Instabilidade meiótica da expansão patogênica (CAG)n=38 no gene HTT em caso familiar de doença de Huntington. Revista Científica da Faculdade de Medicina de Campos. https://doi.org/10.29184/1980-7813.rcfmc.114.vol.5.n2.2010
38. Bastos, S. N. R., & Silva, A. C. (2019). COLECTOMIA SUBTOTAL POR MEGACÓLON EM FELINO – RELATO DE CASO.
39. Bau, V., Deschauer, M., & Zierz, S. (2009). Chronisch progressive externe Ophthalmoplegie – Symptom oder Syndrom?. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/s-0028-1109800
40. Bentele, K. (2005). Neonatal Seizures. Neuropediatrics. https://doi.org/10.1055/s-2005-867945
41. Berber, İ., Erkurt, M. A., Kuku, İ., Köroğlu, M., Kaya, E., & Ünlü, S. (2013). A Rare Disease in Adult: Langerhans Cell Histiocytosis. World Journal of Oncology. https://doi.org/10.4021/wjon.v4i3.663
42. Berker, D. D., Piraccini, B. M., Ruben, B. S., & Baran, R. (2018). Nail Disorders in Childhood. John Wiley & Sons, Ltd eBooks. https://doi.org/10.1002/9781119323396.ch10
43. Beukeboom, L. W. (1992). Chromosoominprenting. Ouders maken indruk.
44. Bezerra, T. A. R., Rizzi, V. T. P. S., Madeiras, F. D., Chiu, B. S. L., Carvalho, R. O., Cruz, A. C. C., Anastácio, L. F., Yamane, A. E., Maciel, J. R. C., Vivas, A. D., Hazarbassanov, R. M., & Freitas, M. R. I. D. (2023). ANÁLISE E DESCRIÇÃO DE PLANO TERAPEUTICO SINGULAR A GESTANTE ADOSLESCÊNTE PORTADORA DE TRANSTORNO DE BORDERLINE. Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida. https://doi.org/10.36692/15n1-06
45. Biazi, D., França, J., Bezerra, L., & Fernandes, B. (2022). SÍNDROME DE RICHTER: TRANSFORMAÇÃO CLÍNICA E HISTOLÓGICA DE LEUCEMIA LINFOCÍTICA CRÔNICA ‒ LINFOMA LINFOCÍTICO DE PEQUENAS CÉLULAS. Hematology Transfusion and Cell Therapy. https://doi.org/10.1016/j.htct.2022.09.1084
46. Bieganowska, K., Miszczak‐Knecht, M., Rękawek, J., Borucka-Mankiewicz, M., Szymaniak, E., & Popowska, M. B.-P. I. E. (2005). Wrodzony zespół wydłużonego QT z głuchotą — zespół Jervella i Lange-Nielsena. Folia Cardiologica.
47. Birch, S. (2023). Venous thromboembolism in Klinefelter syndrome: a clot in the knowledge?. Trends in Urology & Men s Health. https://doi.org/10.1002/tre.945
48. Blüher, S., & Vilser, C. (2018). Syndromale Formen der Adipositas. Adipositas - Ursachen Folgeerkrankungen Therapie. https://doi.org/10.1055/s-0038-1676673
49. Boedeker, C. C., Erlic, Z., Kahnoski, R. J., Kontny, U., Gimenez‐Roqueplo, A., Cascón, A., Robledo, M., Campos, J. M. D., Nederveen, F. H. V., Krijger, R. R. D., Burnichon, N., Gaal, J., Walter, M. A., Reschke, K., Wiech, T., Weber, J., Rückauer, K., Plouin, P.-F., Darrouzet, V., ... Neumann, H. P. (2009). Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2009-0354
50. Boisramé, S., Lelièvre, J., Moine, P. L., & Pers, J. (2010). Syndrome de Kostmann et cavité buccale : présentation d’un cas et revue de la littérature. Médecine Buccale Chirurgie Buccale. https://doi.org/10.1051/mbcb/2009037
51. Borba, A. C. G., Ribeiro, P. V. S., Guimarães, M. N., Daher, H. C. D., Ferreira, L. D., Carvalho, A. B., Lucena, T. A. D., Quintanilha, H. G., Oliveira, M. E. H., Akasaka, G. M. N., Ahmed, N. G., Duarte, B. S., & Rocha, I. G. (2023). Síndrome de Costello: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-154
52. Borkoski, S., Pérez, D., Falcón, J. C., & Ramos, Á. (2013). Síndrome de Jervell y Lange-Nielsen. Revista de otorrinolaringología y cirugía de cabeza y cuello. https://doi.org/10.4067/s0718-48162013000300010
53. Borovikov, A., Markova, T. V., & Shchagina, O. (2019). A new allelic variant of periventricular nodular heterotopia type 7 in a patient with adrenogenital syndrome due to a 21-hydroxylase deficiency. Nauchno-prakticheskii zhurnal «Medicinskaia genetika». https://doi.org/10.25557/2073-7998.2019.06.50-56
54. Bortolini, A. G. C., Silva, C. M. S. D., & Bassi, L. A. (2008). Como identificar e trabalhar com crianças que apresentam TDA/H. Revista Chão da Escola. https://doi.org/10.55823/rce.v7i7.57
55. Bortoluzzi, A. S., Magnagnagno, O. A., & Nobre, L. F. M. (2018). NEUROFIBROMATOSE TIPO 1 - IMPACTOS NA INFÂNCIA E ADOLESCÊNCIA. Revista Faz Ciência. https://doi.org/10.48075/rfc.v19i29.17040
56. Bosch, J. D. V. D., Huisman, J., & Waal, H. (1996). Personality Development of Adolescents with Hypogonadotropic Hypogonadism. Psychological Reports. https://doi.org/10.2466/pr0.1996.79.3f.1123
57. Bouaziz, N., & Yeim, S. (2013). Les risques d'erreurs diagnostiques chez les mineurs isolés étrangers. Adolescence. https://doi.org/10.3917/ado.085.0625
58. Boy, R., Correia, P. S., Llerena, J. C., Machado-Ferreira, M. D. C., & Pimentel, M. M. G. (2001). Síndrome do X frágil: estudo caso-controle envolvendo pacientes pré e pós-puberais com diagnóstico confirmado por análise molecular. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2001000100017
59. Brandt, D., Trachte, A., Besser, B., Orlowski, S., Bischof, G., Bischof, A., Hoffmann, H., Stamer, T., & Rumpf, H. (2019). Assoziation von Glücksspielsymptomatik und kultureller Herkunftsregion: Befunde aus der MIGUEL-Studie. Suchttherapie. https://doi.org/10.1055/s-0039-1696174
60. Brandão, L. M., Albuquerque, L. D. F., Machado, L. S., Oliveira, L. C., Santos, G. R. P. D., Pereira, G. B., Oliveira, H. V., Sander, R. C., Borges, I. C., Correia, I. M., Borges, V. D. O. C., Morais, R. K. D., Dantas, C. P., Chagas, J. M. D. A., Cucci, C. P., Oliveira, M. B. D., Ribeiro, C. P., Coutinho, L. L. D. A., Matos, R. C. M. D., ... Damasio, Y. D. M. B. (2022). Síndrome de Hutchinson. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv5n5-081
61. Brennand, K. (2016). Is Huntington’s disease a neurodevelopmental disorder?. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aad9760
62. Brinkmann, L., Schweizer, K., & Richter‐Appelt, H. (2007). Behandlungserfahrungen und Behandlungszufriedenheit von erwachsenen Personen mit verschiedenen Formen der Intersexualität. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. https://doi.org/10.1055/s-2007-970629
63. Brogårdh‐Roth, S., Stjernqvist, K., Matsson, L., & Klingberg, G. (2009). Dental anxiety patterns in adolescents born preterm compared with matched controls. International Journal of Paediatric Dentistry.
64. Bufler, J., Christova, L., Alexandrov, A. S., Krampfl, K., Kossev, A., & Ishpekova, B. (2005). Erbliche motorische und sensorische Neuropathie - Typ LOM (HMSN-L) - Elektrophysiologische Charakteristika. Klinische Neurophysiologie. https://doi.org/10.1055/s-2005-866859
65. Bureau, M., Thomas, P., & Genton, P. (2007). てんかん症候群 : 乳幼児・小児・青年期のてんかん学. 中山書店 eBooks.
66. Burger, P., Coutelle, R., Strehle, A., Colin, F., Collot, N., Koolen, D. A., Kleefstra, T., & Mandel, J. (2021). GenIDA : l’histoire naturelle et les comorbidités des troubles du neurodéveloppement d’origine génétique. Enfance. https://doi.org/10.3917/enf2.213.0229
67. Calder, S. D., Boyes, M., Brennan‐Jones, C. G., Whitehouse, A., Robinson, M., & Hill, E. (2023). Do parent‐reported early indicators predict later developmental language disorder? A Raine Study investigation. International Journal of Language & Communication Disorders. https://doi.org/10.1111/1460-6984.12950
68. Cannon, M., & Murray, R. (1998). Neonatal origins of schizophrenia. Archives of Disease in Childhood. https://doi.org/10.1136/adc.78.1.1
69. Caramalac, S. M., Frazílio, F., & Palumbo, M. I. P. (2018). Tremor de cabeça idiopático em cães - relato de dois casos. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. https://doi.org/10.1590/1678-4162-10276
70. Carlsson, J., & Palmqvist, R. (2009). Kognition och nutritionsstatus hos äldre i Blekinge.
71. Carvalho, A. C. A. D., Campos, P. S. F., & Crusoé‐Rebello, I. (2010). Síndrome de Down: aspectos relacionados ao sistema estomatognático. Revista de Ciências Médicas e Biológicas. https://doi.org/10.9771/cmbio.v9i1.4732
72. Carvalho, A. C., Matos, J. E., Lira, S., & Reis, A. C. A. D. (2019). Parésia Hipocaliemica em Adolescente: Um Caso Clínico. Acta Médica Portuguesa. https://doi.org/10.20344/amp.10497
73. Carvalho, D. D. S. D. M., Hirschheiter, C. Â., MAIA​​, R. L., Silva, C. M. D., & Galvão, P. V. M. (2019). Hanseníase: uma doença reemergente na saúde pública brasileira. Multidisciplinary Reviews. https://doi.org/10.29327/multi.2019023
74. Cashdollar, S. (2018). Neither Accidental nor Intended: Pregnancy as an Adolescent Identity Project among Hispanic Teenage Mothers in Doña Ana County, New Mexico.. Grantee Submission.
75. Castilho, S., Susana, T., Porto, F., Gonçalves, C., Silva, F., Olveira, L., Malfa, R., & Ferreira, H. (2023). DOENÇA HEMOLÍTICA FETO E RECÉM-NASCIDO POR INCOMPATIBILIDADE ABO. RELATO DE CASO. Hematology Transfusion and Cell Therapy. https://doi.org/10.1016/j.htct.2023.09.1158
76. Castro, A. F. S., Martins, M. A., Pereira, B. D. F., Guedes, I. P. D. A., Costa, J. M. P., Guimarães, L. C., Rocha, M. D. O. F., Melo, N. A. D., Cavalcanti, R. C., & Pires, J. F. (2023). Consequências do hipotireoidismo congênito no desenvolvimento infantil. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e12714.2023
77. Castro, R. A. A., Valenzuela, E. M. E., & Pacheco, L. C. (2006). Síndrome de Horner congenito secundario a neuroblastoma cervical en un lactante menor. Acta Ortopédica Mexicana.
78. Cavalcante, G. M. R., Carneiro, P. A., Leite, A. K. R. D. M., Bezerra, B. M. O., Brito, B. G. M., Lima, F. E. D. S., Chaves, R. N., Guedes, R. F. D. M., & Aquino-Cortez, A. (2022). TRATAMENTO DE MASTOCITOMA CANINO: REVISÃO DE LITERATURA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-15-3-12
79. Cerda, C. B., López-Uriarte, A., Puente, V. G., Sánchez, M. D. C. E., & Villarreal, L. (2013). Secuencias del cromosoma «Y» en una niña con síndrome de Turner: implicaciones clínicas. Revista Mexicana de Pediatría.
80. Chadli, A., Nsame, D., Aziz, S. E., Ghomari, H. E., & Farouqi, A. (2013). Aspects cliniques du syndrome de Noonan. Médecine thérapeutique / Médecine de la reproduction, gynécologie et endocrinologie. https://doi.org/10.1684/mte.2013.0493
81. Charman, T., Pasco, G., Hendry, A., Bazelmans, T., Narvekar, N., Goodwin, A., Halkola, H., Agyapong, M., Holman, R., Ali, J. B., Ersoy, M., Johnson, M. H., Pickles, A., & Jones, E. J. H. (2023). Three year outcomes in infants with a family history of autism and/or attention deficit hyperactivity disorder. JCPP Advances. https://doi.org/10.1002/jcv2.12189
82. Charters, L. (2019). Connecting the dots: Genetics and impact on diabetic retinopathy.
83. Chehin, M. B. (2016). Preservação da fertilidade em mulheres no contexto reumatológico – aspectos atuais da reprodução assistida. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2016.15.2.26-31
84. Chen, J., Sallum, J. M. F., Longhitano, S. B., & Brunoni, D. (2000). Anomalias oculares em pacientes portadores de deficiência auditiva genética. Arquivos Brasileiros de Oftalmologia. https://doi.org/10.1590/s0004-27492000000600007
85. Cheng, J., Liu, H., Lin, W., & Tsai, F. (2020). Additional file 4 of Identification of contributing genes of Huntington’s disease by machine learning. Figshare. https://doi.org/10.6084/m9.figshare.13279151
86. Chirano, C. B., Resende, G. B. D., Ribeiro, E. A. D. O., & Soares, K. S. (2018). SÍNDROME DE RETT: abordagem odontológica. Revista da AcBO - ISSN 2316-7262.
87. Christofolini, D. M., Pinheiro, F. S., Bianco, B., Melaragno, M. I., Ramos, M. A., Brunoni, D., Alves, F. G., & Barbosa, C. P. (2009). Síndrome de tremor e ataxia associada ao X frágil: rastreamento por PCR em amostra de idosos. Arquivos Brasileiros de Ciências da Saúde. https://doi.org/10.7322/abcs.v34i1.141
88. Cháves, M. C. (2000). Tartamudez de aparición tardía: tartamudez neurogènica. Revista Facultad Ciencias de la Salud: Universidad del Cauca.
89. Clayton, P., Tato, L., Quinteiro, S., Colle, M., Jaaskelainen, J., Schnieper-Samec, S., Raelson, J., Malo, N., Olivier, C., & Chatelain, P. (2010). Genetic Markers Are Associated with 1 Month Change in IGF-I and Growth Response at 1 Year in Growth Hormone Deficiency (GHD) but Not in Turner Syndrome (TS) during Treatment with GH: The PREDICT Study and Follow-Up.. https://doi.org/10.1210/endo-meetings.2010.part3.or2.or35-4
90. Cocha, Q., & Estefanía, C. (2020). Estimulación temprana en el desarrollo motor grueso de un paciente masculino deficiente visual de 12 meses.
91. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Abnormalities of child development. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0004
92. Correro, A. N., Gauthreaux, K., Perales‐Puchalt, J., Chen, Y., Chan, K. C. G., Kukull, W. A., & Flatt, J. D. (2023). Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-220309
93. Corsello, G., Piccione, M., Vecchio, D., Consiglio, V., & Lauricella, S. (2013). X-linked intellectual disability.
94. Costa, J. C. D. L., Reis, A. B. D. S., Nascimento, H. C., & Santos, R. P. (2016). Evolução sintomatológica de uma paciente portadora de neurofibromatose tipo 1: relato de caso. Revista de Ciências Médicas e Biológicas. https://doi.org/10.9771/cmbio.v15i1.13495
95. Costa, J. R. P., Simões, M. E. C., Silva, M. L. P. E., Sasso, V. P. D., Rocha, I. R., Figueiredo, R. A. H., Silva, I. F., Ribeiro, L. P., Gonçalves, T. C. D., & Aquino, I. P. D. (2023). Síndrome dos ovários policísticos: aspectos etiopatogênicos, métodos diagnósticos e condutas terapêuticas. Brazilian Journal of Development. https://doi.org/10.34117/bjdv9n3-223
96. Costa, L. F., Caixeta, L. V. V., Carvalho, L. O. R. D., Barbosa, C. O., Ferreira, I. B., Reis, V. H. S., Toledo, L. F. E. S. D., Neto, L. A. D. R. M., Olavarria, R. D. C., Oliveira, A. G. L., & Gomes, K. H. (2023). Síndrome de Lynch: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-168
97. Costa, Y. A., Menezes, S. A. D., Silva, F. S. H. D., Cavalcante, M. T. B. D. S., Júnior, A. S. D. C., & Santos, C. R. B. D. (2016). SÍNDROME DE HUTCHINSON-GILFORD: UM ESTUDO DA LITERATURA. Encontro de Extensão, Docência e Iniciação Científica (EEDIC).
98. Cronk, N. J. (2006). Causes of comorbidity among internalizing disorders of childhood and adolescence : the roles of neuroticisim, genes and environment. https://doi.org/10.32469/10355/4445
99. Csorba, J., Ferencz, E. S., Solymossy, M., Vados, M., Páli, E., & Nagy, E. (2007). Diagnoses and detailed behavioural characteristics of self-injurious adolescent outpatients. Mentálhigiéné és Pszichoszomatika. https://doi.org/10.1556/mental.8.2007.2.1
100. Culver, J. O., Ricker, C., Bonner, J. D., Kidd, J., Sturgeon, D., Hodan, R., Kingham, K., Lowstuter, K., Chun, N. M., Lebensohn, A., Rowe‐Teeter, C., Levonian, P., Partynski, K., Lara‐Otero, K., Hong, C., Pichardo, J. M., Mills, M., Brown, K., Lerman, C., ... Idos, G. (2020). Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. https://doi.org/10.1002/cncr.33357
101. Cunha, I. L. B. D., Rodrigues, V. H. V., Wanderley, L. S., & Brito, I. R. (2022). ANOMALIAS CONGÊNITAS CRANIAIS EM CÃES NEONATOS: REVISÃO DE LITERATURA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-15-3-1
102. Cunha, K. S., Gelle, M., Neto, R. S. D. M., & Lopes, V. S. (2007). Genética da neurofibromatose tipo 1. Revista de Ciências Médicas e Biológicas. https://doi.org/10.9771/cmbio.v6i3.4396
103. Dahanayake, D., & Rajaratne, P. K. D. H. J. L. D. S. (2021). “My daughter is unwell”: Fears of a mother with a major psychiatric illness. Sri Lanka Journal of Psychiatry. https://doi.org/10.4038/sljpsyc.v12i2.8309
104. Dantas, É. L. R., Pontes, M. L., Fernandes, P. F. C. C. B., Ribeiro, E. M., & Daher, E. D. F. (2013). Hadju-Cheney syndrome: kidney disturbs in a case report. Brazilian Journal of Nephrology. https://doi.org/10.5935/0101-2800.20130026
105. Danziger, N., & Jc, W. (2009). L'insensibilité congénitale à la douleur. Neurologie com. https://doi.org/10.1684/nro.2009.0060
106. Dedushi, K., Hyseni, F., Musa, J., Saliaj, K., Vokshi, V., Guy, A., Bhatti, A. U. R., Rahman, A., Tahir, M., Rakovica, L., Rahman, M., & Shatri, J. (2021). A rare case of anophthalmia without any family history and antenatal risk factors. Radiology Case Reports. https://doi.org/10.1016/j.radcr.2021.09.001
107. Demir, Z., Böckelmann, S., Kutschke, G., Mark, S., Abu‐Tair, T., & Mildenberger, E. (2010). Ungewöhnlich milder Verlauf eines Undine-Syndroms bei einem reifen Neugeborenen und familiärer Häufung. Klinische Pädiatrie. https://doi.org/10.1055/s-0030-1261599
108. Demirbilek, H., Küpeli, S., Özbek, M., Saygı, S., & Yıldırım, A. T. (2013). Onbuçuk yaşındaki bir kız çocuğunda Nörofibromatoziz tip 1 ve otoimmün hipertiroidizm birlikteliği. DOAJ (DOAJ: Directory of Open Access Journals).
109. Deus, G., Jeronimo, L., Borges, A. A., & Sales, B. (2022). O cenário das doenças raras no Brasil: a importância da triagem neoatal e do aconselhamento genético. Editora COLAB eBooks. https://doi.org/10.51781/978658692022240
110. Devys, D. (1996). Etude moleculaire de deux maladies dues a des expansions de trinucleotides.
111. Diaz‐Gil, D., Kodolitsch, Y. V., Kozlik‐Feldmann, R., Müller, G., Olfe, J., Stark, V., Wipper, S., & Mir, T. (2020). Neonatal Marfan’s Syndrome in Its Maximum Expression: An Ambitious Course with Multidisciplinary Approach until Adolescence. The Thoracic and Cardiovascular Surgeon. https://doi.org/10.1055/s-0040-1705519
112. Dijk, M. T. V., Pokhvisneva, I., Patel, S., Cha, J., Gameroff, M. J., Posner, J., Meaney, M. J., Weissman, M. M., Silveira, P. P., & Talati, A. (2022). P227. Polygenic Risk for Depression is Associated With Depressive Symptoms and Suicide Attempts and Interacts With Adverse Childhood Environments to Predict Decreased Dentate Gyrus Structure in Offspring at Family Risk for Depression. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2022.02.461
113. Doležalová, P., Böhm, M., Lachmann, H. J., Modesto, C., Touitou, I., Woo, P., Finetti, M., Hentgen, V., Cantarini, L., Benedetti, F. D., Gallizzi, R., Obici, L., Manna, R., Gallo, E., Ruperto, N., & Gattorno, M. (2013). PW02-022 - Recurrent fever syndromes: multiple gene mutations. Pediatric Rheumatology. https://doi.org/10.1186/1546-0096-11-s1-a162
114. Donaghy, M. (2001). Motor Neuron Diseases. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0002317
115. Donohue, M. O., Pino, L. R., Valdivia, O. F., Ventura, C. A., & Becerra, C. L. (1998). El prematuro y su manejo. Revista Peruana de Pediatría. https://doi.org/10.61651/rped.1998v51n1-2p15-20
116. Dowling, P., Fleming, P. S., Gorlin, R. J., King, M., Nevin, N. C., & McEntagart, M. (2001). The KBG syndrome, characteristic dental findings: a case report. International Journal of Paediatric Dentistry. https://doi.org/10.1046/j.1365-263x.2001.00231.x
117. Dragon, J. M., Grewal, M. R., Irace, A. L., Morales, E. E. G., & Golub, J. S. (2023). Prevalence of Subclinical Hearing Loss in the United States. Otolaryngology. https://doi.org/10.1002/ohn.326
118. Dubovsky, S. (2009). Is Binge Eating Always the Same Problem. Journal watch. https://doi.org/10.1056/jp200906290000003
119. Duvoisin, R. C. (1988). Genetische Faktoren beim Parkinson-Syndrom. https://doi.org/10.1007/978-3-89935-547-5_1
120. Dziwornu, E., Dey, N. E. Y., Ansah, K. O., Arthur-Holmes, F., Duah, H. O., Amoah, P. A., & Agbadi, P. (2021). Association between remembering difficulty and anxiety and depression among children in Ghana. Journal of Affective Disorders Reports. https://doi.org/10.1016/j.jadr.2021.100212
121. Dürr, A., Gargiulo, M., & Feingold, J. (2005). Les tests présymptomatiques en neurogénétique. médecine/sciences. https://doi.org/10.1051/medsci/20052111934
122. Epplen, J. T., & Wieczorek, S. (2007). Trinucleotide Repeat Expansions: Mechanisms and Disease Associations. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0005067.pub2
123. Escalera, S., Alfonso, G., Freitas, J., Maymó, D., & Vigna, C. (2023). Histiocitosis de células de Langerhans en adultos. Reporte de 2 casos. Revista Hematología. https://doi.org/10.48057/hematologa.v26i3.475
124. Espinoza, J. (2002). CONSTIPACIÓN EN PEDIATRÍA. Revista chilena de nutrición. https://doi.org/10.4067/s0717-75182002000300001
125. Eugster, E. A., & Palmert, M. R. (2006). Precocious Puberty. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.91.9.9997
126. Faleiro, I. D. F., Dultra, J. R., Abreu, V. L., Oliveira, L. H. D., Zambrin, G. C. V. B., Nicolai, N. L., Vargas, I. C., Frazão, C. Q., Gaboardi, K. R., Souza, A. A. D., Antunes, A. M., Júnior, S. D. F., Castro, M. R. D., & Silva, I. S. (2023). Síndrome de Rett: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-174
127. Fatima, B., Ahmad, A., Khan, T., & Ahmad, R. (2019). Crigler Najjar Syndrome [Type II] with Pregnancy: Case Report. International Journal of Human and Health Sciences (IJHHS). https://doi.org/10.31344/ijhhs.v4i1.121
128. Fazzi, E., Molinaro, A., Micheletti, S., Galli, J., & Rossi, A. (2016). Évaluation et prise en charge des troubles visuels de l’ancien prématuré. Contraste. https://doi.org/10.3917/cont.043.0089
129. Fedorova, L., Savenko, I. V., Vikhnina, S. M., & Boboshko, M. Y. (2021). Childhood hearing screening: achievements, difficulties, and possible ways to improve. Russian Bulletin of Otorhinolaryngology. https://doi.org/10.17116/otorino20218601182
130. Felderbauer, P., Stricker, I., Bulut, K., Uhl, W., Tannapfel, A., & Schmidt, W. (2008). Histopathologische Aspekte der genetisch bedingten Pankreatitis: Gibt es spezifische histologische oder onkogenetische Kriterien?. Zeitschrift für Gastroenterologie. https://doi.org/10.1055/s-0028-1089521
131. Ferguson‐Smith, M., & Connor, J. M. (1988). Durch ein Gen determinierte Krankheiten. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-72401-5_15
132. Ferguson‐Smith, M., & Connor, J. M. (1988). Multifaktorielle Vererbung. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-72401-5_9
133. Ferguson‐Smith, M., & Connor, J. M. (1988). Prävention und Behandlung genetischer Erkrankungen. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-72401-5_20
134. Ferraz, M. H. C., & Murao, M. (2007). Diagnóstico laboratorial da doença falciforme em neonatos e após o sexto mês de vida. Revista Brasileira de Hematologia e Hemoterapia. https://doi.org/10.1590/s1516-84842007000300005
135. Ferreira, H., & Rizzatti‐Barbosa, C. M. (2000). Microcefalia Primária Grave — Revisão de 10 Casos. Portuguese Journal of Pediatrics. https://doi.org/10.25754/pjp.2000.5319
136. Ferreira, J. D. S., Alcoforado, A. S., Aguiar, B., Neto, E. G. M., & Dantas, A. F. M. (2016). Hipotricose congênita em potra. Pesquisa Veterinária Brasileira.
137. Fonseca, C. R., Fonseca, L. L. C. G. D., Figueiredo, K. F., Santos, C. Q. E., Silva, L. L., Moura, V. L. D. S., Serrão, A. L. V., Moraes, L. D. F. M. D., Correia, P. S., Bastos, E. F., & Llerena, J. C. (2018). Translocação balanceada herdada t(8;19)(q12;q13)mat concomitante à deleção de 15q11.2 em um paciente com Síndrome de Angelman (SA) - A citogenética clássica não evanesce. Semina Ciências Biológicas e da Saúde. https://doi.org/10.5433/1679-0367.2017v38n1suplp248
138. Fonseca, P., Borges, T., Azevedo, M., Silva, C. G., & Costa, F. M. (2000). Hipotiroidismo Adquirido — 3 Casos Clínicos. Portuguese Journal of Pediatrics. https://doi.org/10.25754/pjp.2000.5387
139. Frade, M. T. S., Ferreira, J. D. S., Nascimento, M. J. R. D., Aquino, V. V. F. D., Macêdo, I. L. D., Carneiro, R. D. S., Souza, A. P. D., & Dantas, A. F. M. (2018). Doenças do sistema nervoso central em cães. Pesquisa Veterinária Brasileira. https://doi.org/10.1590/1678-5150-pvb-5100
140. Franco, I. D. A., Aragão, M. D. M., Braga‐Neto, P., Avelino, M. A., Pedroso, J. L., Marussi, V. H. R., Freitas, L. F., Masruha, M. R., & Barsottini, O. G. P. (2018). The cerebellar histiocytosis. Neurology. https://doi.org/10.1212/wnl.0000000000006036
141. Francou, B. (2016). Contribution à la caractérisation de nouveaux gènes impliqués dans les hypogonadismes hypogonadotropes : caractérisation des mécanismes moléculaires et cellulaires.
142. Franz, A. R., Steinmacher, J., Pohlandt, F., Bode, H., & Kron, M. (2006). Neurokognitive Entwicklung Frühgeborener (FG) mit einem Geburtsgewicht &lt;1500g im korrigierten Alter von 5,7 Jahren. Neuropediatrics. https://doi.org/10.1055/s-2006-946286
143. Franz, A. R., Steinmacher, J., Pohlandt, F., Bode, H., & Kron, M. (2006). Neurokognitive Entwicklung Frühgeborener (FG) mit einem Geburtsgewicht &lt;1500g im korrigierten Alter von 5,7 Jahren. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/s-2006-946020
144. Frare, A., Bizzotto, J. Q., Ribeiro, L. P., & Borges, N. M. (2020). Aspectos genéticos relacionados ao Transtorno do Espectro autista (TEA). Brazilian Journal of Development. https://doi.org/10.34117/bjdv6n6-372
145. Freire, J. F. P., Leite, A. K. R. D. M., Aquino-Cortez, A., Bezerra, B. M. O., Lima, F. E. D. S., & Guedes, R. F. D. M. (2022). ASPECTOS CLÍNICO-LABORATORIAIS NA IMUNODEFICIÊNCIA VIRAL FELINA: UMA REVISÃO INTEGRATIVA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-15-3-7
146. Frías, M. Á. N., Fernández, J. M., Castillo, H. A., Díaz, M. S., Ovalle, C., & León, D. (2008). Heterotopia neuronal glial asociada a fisura palatina. Revista de la Asociación Dental Mexicana.
147. Fuemmeler, B. F., Sheng, F., Schechter, J. C., Elizabeth, K., Zucker, N., Majors, A., Maguire, R. L., Murphy, S. K., Hoyo, C., & Kollins, S. H. (2020). Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood. Pediatric Obesity. https://doi.org/10.1111/ijpo.12631
148. Galanopoulou, A. S., & Moshé, S. L. (2002). Desnutrição e epilepsia. Jornal de Pediatria. https://doi.org/10.1590/s0021-75572002000100004
149. Gallan, L. (2013). La morte improvvisa "sine materia". Sindrome long-Qt congenita o indotta da farmaci. Incidenza del fenomeno nello sportivo..
150. García, M. E. G., Álvarez, C. F., Marinas, V. R., Huerta, A. J. G., Miranda, M., González-Rodríguez, A. P., Casas, J. G., Tassa, J. M. D. L., & García, J. F. (2008). [A series of 618 cases of monoclonal gammopathies of undetermined significance: predictive factors of disappearance of monoclonal component or evolution to malignant gammopathies].. Revista Clínica Española. https://doi.org/10.1157/13123188
151. García, M. E. T. (2020). Exposición prenatal al alcohol. Deleted Journal. https://doi.org/10.32399/icuap.rdic.2448-5829.2020.16.272
152. Gargiulo, M., & Dürr, A. (2018). Liminalité après un diagnostic génétique présymptomatique.
153. Gargiulo, M., & Dürr, A. (2018). Traité de bioéthique. Érès eBooks. https://doi.org/10.3917/eres.hirsc.2018.01.0237
154. Gascoin-Lachambre, G., Buffat, C., Mondon, F., Rigourd, V., Siméoni, U., Vaiman, D., & Barbaux, S. (2009). Altérations de l’expression des gènes dans les Retards de Croissance Intra-Utérin. Médecine et Nutrition. https://doi.org/10.1051/mnut/2009451025
155. Gesing, J., Stoltze, A., Göpel, E., Pfäffle, R., & Kieß, W. (2023). Angeborene und erworbene Hypothyreose: Wie interpretiere ich Schilddrüsenwerte richtig?. Kinder- und Jugendmedizin. https://doi.org/10.1055/a-1991-3455
156. Ghailan, M. R., Benhalima, H., Rabeh, G., Oujilal, A., Benbouzid, A., Bencheikh, R., Essakali, L., Boulaich, M., & Kzadri, M. (2007). Syndrome de Gorlin-Goltz : à propos d’un cas. Médecine Buccale Chirurgie Buccale. https://doi.org/10.1051/mbcb/2007012
157. Ghitiu, A.-O., Cîrlig, D., Georgescu, E., Grigore, C., Pascu, C., Blaga, R., Albeanu, A., & Falup‐Pecurariu, O. (2020). NEUROFIBROMATOSIS TYPE I: CLINICAL CASE NEUROFIBROMATOZA TIP I : CAZ CLINIC. Jurnal Medical Brasovean. https://doi.org/10.31926/jmb.2020.1.18
158. Giansily, M., & Schved, J. (2000). Les déficits constitutionnels en facteur VII. Hématologie.
159. Ginting, S. A., Ariani, A., & Sembiring, T. (2016). Terapi Diet pada Autisme. Sari Pediatri. https://doi.org/10.14238/sp6.1.2004.47-51
160. Gkesoglou, T., Pervanidou, P., Bozikas, V. P., & Agorastos, A. (2022). Neurobiology of early life traumatic stress and trauma: Prolonged neuroendocrine dysregulation as a neurodevelopmental risk factor. Psychiatriki. https://doi.org/10.22365/jpsych.2022.059
161. Gomes, G. D. S., Madruga, M. T. D. F., Xavier, J. G. S., Vieira, A. B. C., Oliveira, M. M. W., Varão, F. D. S., Fumeiro, R. D. C., Carvalho, L. P. O. D., Queiroz, P. F. D. S., Araújo, L. Z., & Lima, L. R. C. D. (2023). Doença de Leigh: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-244
162. Gomes, S., Almeida, J., Ferrão, J., Matoso, E., Carreira, I. M., & Oliveira, G. (2010). Patologia do neurodesenvolvimento por anomalia cromossómica da região crítica do cromossoma 15 (q11-q13) - relação genótipo-fenótipo. Portuguese Journal of Pediatrics. https://doi.org/10.25754/pjp.2010.4418
163. Gomes, T. M., Ludwig, G., & Andrade, E. P. D. (2022). Síndrome de Horner pediátrica secundária à canulação da veia jugular interna: relato de caso. eOftalmo. https://doi.org/10.17545/eoftalmo/2021.0009
164. Gon, K. J., Mi, Y., & Baik, B. J. (2006). 선천성 다수 영구치 결손 환아의 증례보고. THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY.
165. González, A. C., Marqués, J. G., Román, A. C., Unturbe, F. M., & Lapedriza, N. P. (2007). Desarrollo cognitivo tras un traumatismo craneoencefálico en la infanci= Cognitive development after a traumatic brain injury in childhood /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v6i2.3797
166. Gonçalves, A. S. L., Souza, A. B. D., Pires, G. I., Rezende, A. A. A. D., & Calábria, L. K. (2022). ASPECTOS GENÉTICOS E BIOQUÍMICOS DE HTR1B NO TRANSTORNO DO DÉFICIT DE ATENÇÃO COM HIPERATIVIDADE. Revista Multidisciplinar em Saúde. https://doi.org/10.51161/rems/2311
167. Gosai, M. M., Hariyani, H. B., Sadadia, M., Purohit, P. H., & Asti, B. N. (2010). Hutchinson Gilford Progeria Syndrome. National journal of integrated research in medicine.
168. Gracia‐Darder, I., Boix-Vilanova, J., & Martín‐Santiago, A. (2021). Hemangiomas congénitos no involutivos (NICH) con crecimiento postnatal. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2019.09.015
169. Grasser, M., Führer, M., Duroux, A., Borggräfe, I., Koletzko, S., & Borasio, G. D. (2008). Unterschiedliche Wege bei gleicher Erkrankung in der Kinderpalliativmedizin: zwei schwere Fälle von Dyskeratosis congenita. Zeitschrift für Palliativmedizin. https://doi.org/10.1055/s-0028-1088464
170. Grisham, J. R., Anderson, T., Poulton, R., Moffitt, T. E., & Andrews, G. (2009). Childhood neuropsychological deficits associated with adult obsessive–compulsive disorder. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.bp.108.056812
171. Grossman, A., Ismailov, S., Kulmirzayeva, M., Urmanova, Y., & Gilazitdinov, K. (2019). Конституціональна затримка росту і пубертату у хлопчиків: огляд літератури. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). https://doi.org/10.22141/2224-0721.15.5.2019.180045
172. Grübling, N., Darkovski, J. V., Mickan, F., Wimberger, P., & Goeckenjan, M. (2021). Dürfen oder sollen Frauenärzt:innen Patientinnen mit Endometriose nach sexuellen und häuslichen Gewalterfahrungen befragen?. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-0041-1730784
173. Guen, T. L. (2013). Caractérisation phénotypique et moléculaire de déficiences humaines liées à des dysfonctions des télomères et / ou de la réparation de l’ADN.
174. Gulati, S., Goud, E. V. S. S., Agrawal, A., Pani, P., Nishant, K., Pattnaik, S. J., & Gupta, S. (2021). Implications of Down’s syndrome on oral health status in patients. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/jfmpc.jfmpc_885_21
175. Gupta, A., & Kushwaha, S. (2019). Maternally Inherited Huntington Disease and Paternally Inherited Neurofibromatosis Type-1 In an Individual- A Rare Co-Occurrence. Journal of Neurology and Neuromedicine. https://doi.org/10.29245/2572.942x/2019/2.1244
176. Gupta, D. V., & Goyal, S. (2005). Cornelia de-Lange syndrome. Journal of Indian Society of Pedodontics and Preventive Dentistry. https://doi.org/10.4103/0970-4388.16026
177. Gwinn, K., Crook, R., Lincoln, S., Adler, C. H., Caviness, J. N., Hardy, J., & Farrer, M. J. (2000). A kindred with Parkinson’s disease not showing genetic linkage to established loci. Neurology. https://doi.org/10.1212/wnl.54.2.504
178. Gökçora, İ. H., Turan, C., & Akgül, H. (1988). Hirschsprung Hastalığının Tanısına Çağdaş Yaklaşım. Turkiye Klinikleri Tip Bilimleri Dergisi.
179. Göpel, E., Stein, R., Gesing, J., Stoltze, A., Pfäffle, R., & Kieß, W. (2023). Wachstumsstörungen – zu klein, zu groß oder doch normal?. Kinder- und Jugendmedizin. https://doi.org/10.1055/a-1989-2863
180. Habernig, S., Kau, T., Rogatsch, H., & Hausegger, K. (2007). Intravenöse Selbstapplikation von elementarem Quecksilber. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-2007-962885
181. Habib, W. A. (2016). Identification de nouveaux mécanismes moléculaires dans les pathologies de croissance fœtale et postnatale des syndromes de Beckwith-Wiedemann et de Silver-Russell : approche génétique et épigénétique.
182. Haddam, M., Fedala, S., Chentli, F., Zenati, A., Youcef, R. S., & Saraoui, F. (2013). Family Multiple Pituitary Deficiencies Associated to Pituitary Process: Which Diagnosis?. International Journal of Clinical Case Reports. https://doi.org/10.5376/ijccr.2013.03.0011
183. Halimi, S. (2013). Le « Dead-in-bed » syndrome, ou la « mort subite dans son lit » du jeune diabétique de type 1 : rare, ou méconnu ?. Médecine des Maladies Métaboliques. https://doi.org/10.1016/s1957-2557(13)70522-4
184. Haltrich, I., & Fekete, G. (2019). Új diagnosztikai módszerek a ritka betegségek felismerésében. Magyar Tudomány. https://doi.org/10.1556/2065.180.2019.5.5
185. Hanna‐Wakim, R., Enright, A. M., & Gutierrez, K. (2009). Neurological sequelae of congenital perinatal infection. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581281.034
186. Hannigan, L. J., Askeland, R. B., Ask, H., Tesli, M., Corfield, E. C., Ayorech, Z., Magnus, P., Njølstad, P. R., Øyen, A., Stoltenberg, C., Andreassen, O. A., Ronald, A., Smith, G. D., Reichborn‐Kjennerud, T., & Havdahl, A. (2021). Developmental milestones in early childhood and genetic liability to neurodevelopmental disorders. Psychological Medicine. https://doi.org/10.1017/s0033291721003330
187. Hansen, B. H., Andresen, H. N., Gjesvik, J., Thorsby, P. M., Nærland, T., & Knudsen, S. (2023). Associations between psychiatric comorbid disorders and executive dysfunctions in hypocretin-1 deficient pediatric narcolepsy type1. Sleep Medicine. https://doi.org/10.1016/j.sleep.2023.06.021
188. Hansen, P. R., & Manniche, V. (1993). [Recklinghausen neurofibromatosis in children].. PubMed.
189. Harper, P. S. (1996). New genes for old diseases: the molecular basis of myotonic dystrophy and Huntington's disease. The Lumleian Lecture 1995.. PubMed.
190. Harper, P. S. (2009). Children with myotonic dystrophy. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199571970.003.0004
191. Hartmann, A. C. D. A., Firmo, C. R., Alves, G. A. D. ́. ́. O., Couri, J. C. D. C., Moura, L. S. R. D., BOAVENTURA, J. V., Carvalho, L. D. S., Cruz, T. B. F. D., Fonseca, C. A. G. D., & Araujo, J. V. G. (2023). Doença de Cushing - aspectos epidemiológicos, fisiopatológicos e manejo terapêutico. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n4-210
192. Havdahl, A., Wootton, R. E., Leppert, B., Riglin, L., Ask, H., Tesli, M., Askeland, R. B., Hannigan, L. J., Corfield, E. C., Øyen, A., Andreassen, O. A., Tilling, K., Smith, G. D., Thapar, A., Reichborn‐Kjennerud, T., & Stergiakouli, E. (2022). Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2022.1728
193. Hernández, D. Q., Álvarez, A. A. E., Robert, Y., Vila, D. T., Reyes, I. L., & Santos, L. M. (2019). Autismo secundario a variante poco frecuente de mosaicismo del gen FMR1.
194. Hesse, C. (1986). Biochemische und pharmakologische Grundlagen der Psychopharmakatherapie der Depression im Alter. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-85357-9_9
195. Hiller, A., Hagenah, J., Djarmati, A., Hedrich, K., Kock, N., Binkofski, F., Kostic, V., Pramstaller, P., & Klein, C. (2005). Rolle heterozygoter PINK 1-Mutationen beim Parkinson-Syndrom?. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-919315
196. Hoffmann, F. M. R., Rodrigues, P. F., Momensohn-Santos, T. M., Sartorato, E. L., Maciel‐Guerra, A. T., Matas, C. G., & Moraes, V. C. S. D. (2008). Interação entre audiologia e genética no estudo de uma família: a complexidade do diagnóstico molecular e do aconselhamento genético. Revista Brasileira de Otorrinolaringologia. https://doi.org/10.1590/s0034-72992008000500010
197. Hu, H., Wu, L., Liang, D., & Xia, J. (2005). Research progress in nonsyndromic sensorineural hearing loss associated genes. Chinese journal of otorhinolaryngology head and neck surgery.
198. Huffnagel, I. C., Dijkgraaf, M. G. W., Janssens, G. E., Weeghel, M. V., Geel, B. M. V., Poll‐The, B. T., Kemp, S., & Engelen, M. (2019). Additional file 1: of Disease progression in women with X-linked adrenoleukodystrophy is slow. Figshare. https://doi.org/10.6084/m9.figshare.7693295
199. Hulínková, I., & Čižnár, P. (2022). Hereditary angioedema in children: what the paediatrician needs to know. Česko-slovenská pediatrie. https://doi.org/10.55095/cspediatrie2022/003
200. Huret, J. (1997). Phénomène d'anticipation dans les leucémies familiales: vers l'implication de gènes à répétition de trinucléotides?. Hématologie.
201. Hutagaol, D. D. S., & Devaera, Y. (2018). Laporan kasus: Gizi Buruk Sekunder Akibat Kelainan Genetik: Hutchinson-Gilford Progeria Syndrome. Majalah Kedokteran UKI.
202. Hüneburg, R., Heling, D., Marwitz, T., Vilz, T. O., Kalff, J., Perne, C., Aretz, S., Straßburg, C., & Nattermann, J. (2020). Synchrones Auftreten von (prä-)neoplastischen Läsionen im oberen Gastrointestinaltrakt und Karzinomen bei Patienten mit Lynch-Syndrom. Zeitschrift für Gastroenterologie. https://doi.org/10.1055/s-0040-1716084
203. Ipiales, G., & Soledad., R. (2018). Estimulación temprana en el desarrollo motor de una paciente con distrofia miotónica de steinert.
204. Isser, N., & Schwartz, L. L. (2006). Shaken Baby Syndrome. The Journal of Psychiatry & Law. https://doi.org/10.1177/009318530603400303
205. Iturralde, J. L. F., Marani, J., Garcia, M. L., Carbognani, S., Lucerini, V., Damiani, H., & Contardi, J. C. (2020). Malformación genital: disparador del diagnóstico de variantes severas de síndrome de Klinefelter.. Revista chilena de pediatría. https://doi.org/10.32641/rchped.v91i1.1260
206. Iveson, M. H., Ball, E., Whalley, H. C., Deary, I. J., Cox, S. R., Batty, G. D., John, A., & McIntosh, A. M. (2023). Childhood cognitive ability and self-harm and suicide in later life. SSM - Population Health. https://doi.org/10.1016/j.ssmph.2023.101592
207. İsmailoğlu, Ö., Albayrak, B. S., Kabataş, S., & Gülşen, İ. (2009). Rare Cause of Persistent Headache in A Child- Spontaneous Idiopathic Subdural Hematoma. Sinir Sistemi Cerrahisi Dergisi. https://doi.org/10.54306/sscd.2009.75
208. Jabeen, S. A., Sandeep, G., Kandadai, R. M., Meena, A. K., Borgohain, R., & Challa, S. (2016). Adult-onset Leigh′s disease: A rare entity. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.175437
209. Jaffee, S. R., & Widom, C. S. (2023). Resilience to Maltreatment in Early Adulthood Does Not Predict Low Allostatic Load at Midlife.. PubMed. https://doi.org/10.1093/abm/kaac057
210. Jahołkowski, P., Shadrin, A., Jangmo, A., Frei, E., Tesfaye, M., Hindley, G., Haram, M., Rahman, Z., Athanasiu, L., Bakken, N. R., Holen, B., Fominykh, V., Kutrolli, G., Parekh, P., Parker, N., Rødevand, L., Birkenæs, V., Djurovic, S., Frei, O., ... Andreassen, O. A. (2023). Associations Between Symptoms of Premenstrual Disorders and Polygenic Liability for Major Psychiatric Disorders. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2023.1137
211. Jammeli, N., Tej, A., Tilouche, S., Rouis, S., Kebaili, R., Soyah, N., Bouguila, J., & Boughamoura, L. (2018). D�clin neurocognitif chez un enfant ayant une maladie de Bruton: quel diagnostic retenir?. Pan African Medical Journal Conference Proceedings. https://doi.org/10.11604/pamj.cp.2017.4.149.357
212. Jasińska‐Myga, B. (2010). Zespoły pozapiramidowe u osób w podeszłym wieku. Polski Przegląd Neurologiczny.
213. Jeannet, P. Y. (2006). Hypotonie du nourrisson. Médecine & enfance.
214. Jeannet, Y. (2006). Der hypotone Säugling.
215. Jesus, J. V. D., Vidal, D. D. S., Santos, A. B. R., Costa, É. D. N., Silva, L. M. S., Barata, C. V., Jesus, D. S. D., Gomes, A. C., Santos, I. G. D., Silva, W. S. I. D., Oliveira, M. R., & Lima, V. F. S. (2023). PARASITOS GASTROINTESTINAIS DE ROEDORES E SUAS IMPLICAÇÕES NA SAÚDE PÚBLICA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-28-3-3
216. Jones, P. B. (2002). Risk factors for schizophrenia in childhood and youth. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57516-7_13
217. Jourdier, A. (2021). Le syndrome de Kleine-Levin : état des connaissances neuropsychiatriques, revue systématique de la littérature et présentation d’un cas clinique (case report).
218. Juříková, L., Bálintová, Z., & Haberlová, J. (2019). Duchenne muscular dystrophy. Neurologie pro praxi. https://doi.org/10.36290/neu.2019.111
219. Júnior, L. D. M. S., Neville, I. S., Menéndez, D. F. D. S., Neto, M. B. C. D. C., Batista, R. L., Figueiredo, E. G., Andrade, A. F. D., & Teixeira, M. J. (2013). Alterações neuroendócrinas em pacientes com traumatismo cranioencefálico. Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery. https://doi.org/10.1055/s-0038-1625992
220. Kang, S.-G., & Kim, L. (2009). The Sleepy Child. Sleep Medicine and Psychophysiology.
221. Kapitanović, S., Vidak, H. K., & Čačev, T. (2005). Molekularna genetika u racionalnoj dijagnostici neurofibromatoze tipa 1.
222. Kappel, A. D., Lehman, L. L., Northam, W. T., See, A. P., & Smith, E. R. (2023). Pediatric Moyamoya Syndrome Secondary to Tuberculous Meningitis. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000200121
223. Kasar, Z. S. (2023). Yeme Bozuklukları Etiyolojisine Genetik ve Çevre Faktörleri Etkisi. Özgür Yayınları eBooks. https://doi.org/10.58830/ozgur.pub74.c489
224. Kennedy, M. A. (2005). Mendelian Genetic Disorders. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0003934
225. Khambete, N., & Kumar, R. (2012). Genetics and presence of non-syndromic supernumerary teeth: A mystery. Indian Journal of Oral Sciences. https://doi.org/10.4103/0976-6944.106464
226. Kibtiar, M., Akther, R., Islam, M. M., & Rahman, S. A. (2019). Congenital Hypotrichosis Simplex: A Case Report. Bangladesh Journal of Child Health. https://doi.org/10.3329/bjch.v43i1.41219
227. Kinge, J. M., Øverland, S., Flatø, M., Dieleman, J. L., Røgeberg, O., Magnus, M. C., Evensen, M., Tesli, M., Skrondal, A., Stoltenberg, C., Stein, D. J., Håberg, S. E., & Torvik, F. A. (2021). Parental income and mental disorders in children and adolescents: prospective register-based study. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyab066
228. Klein, B. (2016). Les problèmes de santé mentale chez les enfants ayant des troubles neuromoteurs. Paediatrics & Child Health. https://doi.org/10.1093/pch/21.2.97
229. Klein, Á., Albus, C., Aretz, S., & Rohde, A. (2020). Schuld oder Schicksal? – Kognitive Strategien von HNPCC-Mutationsträgerinnen im Umgang mit Kinderwunsch und Vererbungsrisiko. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-0039-3402981
230. Knobel, M., Nogueira, C. R., & Medeiros‐Neto, G. (2001). Genética molecular do hipotireoidismo congênito. Arquivos Brasileiros de Endocrinologia & Metabologia. https://doi.org/10.1590/s0004-27302001000100005
231. Knowlton, R. C., & Msph (2020). Late-Adult-Onset Idiopathic Epilepsy and Dementia Risk. Journal watch. https://doi.org/10.1056/nejm-jw.na51609
232. Ko, H. E., Lee, I. H., Kim, J. H., Shim, E. S., Koh, J. W., & Kim, Y. B. (2002). A Case of Holoprosencephaly. Obstetrics & Gynecology Science.
233. Koehne, P., Hüseman, D., Walch, E. W., Schülke, M., Varon, R., Aust, G., & Obladen, M. (2005). Genetisch bedingte Taubheit bei einem Frühgeborenen mit schwerem postnatalem Verlauf. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/s-2005-871494
234. Kopetsch, C., Scheer, F., Hagenah, J., & Andresen, R. (2021). Endovaskuläre mechanische zerebrale Sinusthrombektomie bei Sinusthrombose eines Teenagers. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/a-1494-3923
235. Kosovska, T. M., & Kosovska, V. O. (2020). ВИПАДОК ХВОРОБИ КРАББЕ В ПЕДІАТРИЧНІЙ ПРАКТИЦІ. Актуальні питання педіатрії акушерства та гінекології. https://doi.org/10.11603/24116-4944.2019.2.10916
236. Kotan, L. D., Eren, E., Turan, İ., Mengen, E., Yüksel, B., & Topaloğlu, A. K. (2019). İdiyopatik Hipogonadotropik Hipogonadizme Neden Olan GNRH1 c.99delA Delesyonunun Klinik ve Genetik İncelemesi. International Journal of Advances in Engineering and Pure Sciences. https://doi.org/10.7240/jeps.615925
237. Koul, R. (2007). Huntington′s disease in all (three) siblings and their one parent. Neurology India. https://doi.org/10.4103/0028-3886.30435
238. Kreyer, R., James, P., Lyutenski, S., & Bloching, M. (2022). Mehr als ein Tinnitus nach dem Hörsturz?. Laryngo-Rhino-Otologie. https://doi.org/10.1055/s-0042-1747458
239. Kreyer, R., James, P., Lyutenski, S., & Bloching, M. (2022). More than one tinnitus after hearing loss?. Laryngo-Rhino-Otologie. https://doi.org/10.1055/s-0042-1746860
240. Kumar, D. S. (2018). Letter to Editor. Pediatric Review International Journal of Pediatric Research. https://doi.org/10.17511/ijpr.2018.i11.10
241. Kusters, C., Klopack, E. T., Crimmins, E. M., Seeman, T. E., Cole, S. W., & Carroll, J. (2023). Short sleep and insomnia are associated with accelerated epigenetic age. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000001243
242. Köylü, O. K., & Kasapkara, Ç. S. (2023). Metabolik Hastalıklarda Göz Bulguları. Turkish Journal of Pediatric Disease. https://doi.org/10.12956/tchd.1271228
243. Lahita, R. G. (2023). Sex and gender influence on immunity and autoimmunity. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1142723
244. Laita, S. G.-B., Azkona, G., Sánchez, B. R., & Liesa, J. P. (2006). Síndrome de disfunción cognitiva.. Argos: Informativo Veterinario.
245. Latta, K. (2006). Primäre Hyperoxalurie – Nur eine Erkrankung bei Kindern?. Aktuelle Urologie. https://doi.org/10.1055/s-2006-947430
246. Lau, E. Y. Y., & Nissen, L. (2019). Prenatal vitamin D for schizophrenia. Australian pharmacist.
247. Lawrence, L. (2013). Some Conditions Linked to Preterm Birth Not Caused by Preterm Birth Itself.
248. Lee, A. Y. S., Rischmueller, M., & Reed, J. H. (2023). Seronegative Sjögren Syndrome: A Forgotten Entity?. The Journal of Rheumatology. https://doi.org/10.3899/jrheum.2023-0247
249. Lee, C., Koo, K. H., & An, J.-H. (2007). The Classification of Idiopathic Scoliosis. Journal of Korean Society of Spine Surgery. https://doi.org/10.4184/jkss.2007.14.1.57
250. Lee, H. S., Ok, J. H., Kim, J. M., & Cho, Y. J. (2013). A Clinical Analysis of Patients with Premature Ovarian Failure: Compliance with Hormonal Treatment. The Journal of Korean Society of Menopause. https://doi.org/10.6118/jksm.2013.19.2.87
251. Lee, J., Croen, L., Backstrand, K. H., Yoshida, C. K., Henning, L. H., Ferriero, D. M., Fullerton, H. J., Barkovich, A. J., & Wu, Y. W. (2005). Caractéristiques maternelles et infantiles associées à l'accident ischémique artériel cérébral périnatal de l'enfant.
252. Lee, S., Shin, D., Lee, S.-H., & Kim, Y.-H. (2006). Monoclonal Gammopathy of Undetermined Significance Presented as a Vasculitic Neuropathy. Journal of the Korean Neurological Association.
253. Lehman, R., & Nance, M. (2013). Family history in juvenile Huntington disease. Neurology. https://doi.org/10.1212/wnl.0b013e31828728ce
254. Lesca, G. (2002). Predictive testing in the context of pregnancy: experience in Huntington's disease and autosomal dominant cerebellar ataxia. Journal of Medical Genetics. https://doi.org/10.1136/jmg.39.7.522
255. Leverger, G., Manea, E., Bellmann, F., Stanescu, P., Mircea, A., Lèbre, A.-S., Rötig, A., & Münnich, A. (2009). Pearson Syndrome in the Neonatal Period. Journal of Pediatric Hematology/Oncology. https://doi.org/10.1097/mph.0b013e3181bbc4ef
256. León, R. C., Ángel, A. G. D., Bustamante, N. A., Reyes, M. D. L. L. R., Sánchez, M. D. C. E., Hernández, E. L., & Ruíz, V. D. C. (2001). Hiperplasia suprarrenal congénita. Acta Pediátrica de México.
257. Li, D., Gordon, C. T., Oufadem, M., Amiel, J., Kanwar, H. S., Bakay, M., Wang, T., Hákonarson, H., & Levine, M. A. (2018). Heterozygous Mutations in TBX1 as a Cause of Isolated Hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-01260
258. Lima, A. L. D. O., Gontijo, A. P. V. P. V., Carmo, A. R., Pinto, A. L., Lamanes, B. D. F., Andrade, S. R. D., Frota, R. V., Lima, S. C. D. S., França, T. K. S. D. O., Perillo, G., Vieira, A. B. C., Cunha, B. E. L., Faria, A. B. D. C. D., Goelzer, D., Medeiros, A. C. P., Schimitz, A. P. D. S., Barreto, E. A. M. B., Mundim, C. E. M., Silva, D. R. F. E., ... Khaoule, I. C. (2022). Síndrome de Morgagni-Stewart-Morel. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv5n5-089
259. Lopes, J., Teixeira, D., Sousa, C., Baptista, A., & Ferreira, E. O. (2020). NF1 microdeletion syndrome: a phenotypical characterization of a rare case of neurofibromatosis type 1. Acta Dermatovenerologica Alpina Pannonica et Adriatica. https://doi.org/10.15570/actaapa.2020.20
260. Luca, M. D., & Gargiulo, M. (2019). Désir d’enfant après un test génétique : entre imprévu et après-coup pour le couple. Dialogue A Journal of Mormon Thought.
261. Luca, M. D., & Gargiulo, M. (2019). Désir d’enfant après un test génétique : entre imprévu et après-coup pour le couple. Dialogue. https://doi.org/10.3917/dia.223.0069
262. Lucena, T. A. D., Quintanilha, H. G., Oliveira, M. E. H., Akasaka, G. M. N., Ahmed, N. G., Duarte, B. S., Rocha, I. G., Borba, A. C. G., Ribeiro, P. V. S., Guimarães, M. N., Daher, H. C. D., Ferreira, L. D., & Carvalho, A. B. G. (2023). Síndrome de Crouzon: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-155
263. Luo, Q., Chen, Q., Wang, W., Desrivières, S., Quinlan, E. B., Jia, T., Macare, C., Robert, G., Cui, J., Guedj, M., Palaniyappan, L., Kherif, F., Banaschewski, T., Bokde, A. L., Büchel, C., Flor, H., Frouin, V., Garavan, H., Gowland, P., ... Feng, J. (2019). Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2018.4126
264. Léger, J. (2021). Dépistage de l’hypothyroïdie congénitale. médecine/sciences. https://doi.org/10.1051/medsci/2021058
265. Léger, J., & Polak, M. (2002). Hypothyroïdie congénitale : du dépistage à la génétique. Médecine thérapeutique / Pédiatrie.
266. López, S., Cajal-Cernuda, C. J., Ordóñez-Blanco, S. M., & Uribe-Rodríguez, A. F. (2008). Identificación y valoración neuropsicológica del riesgo perinatal: instrumentos. Revista Colombiana de Obstetricia y Ginecología. https://doi.org/10.18597/rcog.396
267. López-Pérez, G. P., Fiallos-Mayorga, T. J., Quinatoa-Caba, G. G., & Delgado-Jiménez, J. M. (2021). Hipotiroidismo subclínico en el Embarazo una revisión para la actualización diagnóstica. Dominio de las Ciencias. https://doi.org/10.23857/dc.v7i5.2236
268. Machado, A., Gouveia, T., Ferreira, I., & Rendeiro, M. C. (1998). Doença dos Peroxisomas. Caso Clínico. Portuguese Journal of Pediatrics. https://doi.org/10.25754/pjp.1998.5571
269. Machado, J. D. L., Amaral, W. N. D., Nóbrega, L. M. D., Júnior, J. D. L. M., & Filho, W. N. D. A. (2013). Pseudo-hermafroditismo masculino - relato de caso.
270. Mack, T. M., Cozen, W., Shibata, D., Weiss, L. M., Nathwani, B. N., Hernández, A., Taylor, C. R., Hamilton, A. S., Deapen, D., & Rappaport, E. B. (1995). Concordance for Hodgkin's Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm199502163320701
271. Maddula, K., & Juluru, A. (2016). Prospective Review on Genetic Disorders.
272. Maelicke, A. (2000). Neurodegenerative Erkrankungen: Auslösung durch zufälligen Zelltod?. Nachrichten aus der Chemie. https://doi.org/10.1002/nadc.20000481014
273. Magalhães, A. D. S., Guimarães, G. T. C., Oliveira, N. D. J. S., Azevêdo, S. D. O. L., & Goes, P. P. N. (2022). ANOMALIAS DENTÁRIAS: ESTUDO LONGITUDINAL LIGADO A HEREDITARIEDADE. Diálogos & Ciência. https://doi.org/10.7447/1678-0493.2022v2n2p43-54
274. Mahmood, S., & Naeem, M. (2023). An interesting case of genital infantile hemangioma. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20230887
275. Mahon, S. M., & Waldman, L. T. (2010). Multiple Endocrine Neoplasia 1: Providing Care for the Family. Clinical journal of oncology nursing. https://doi.org/10.1188/10.cjon.657-660
276. Maia, F. F. R., Coelho, A. Z., Andrade, C. G., & Araújo, L. R. (2002). Diagnóstico tardio da síndrome de Klinefelter: relato de caso. Arquivos Brasileiros de Endocrinologia & Metabologia. https://doi.org/10.1590/s0004-27302002000300015
277. Maia, L. V., Santos, B. R., Santos, B. B., Silva, N. S., Jeronimo, L. A. S., Rocha, L. D. R., Xavier, L. L., Araújo, E. P. D., Prado, G. S. B. D., Oliveira, A. K. G. D., Lacerda, T. F., Tomasi, L. E., Borges, M. S., & Souza, M. M. (2023). Síndrome de Lesch-Nyhan: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-194
278. Maier, W., Linz, M., & Hawellek, B. (2000). Genetik der Persönlichkeitsstörungen. PTT - Persönlichkeitsstörungen: Theorie und Therapie.
279. Makwana, R., Makwana, P., Thawani, S., & Malleda, N. R. (2023). Multiple Neonatal Deaths and Alexander's Disease: A Case Report. Journal of Fetal Medicine. https://doi.org/10.1055/s-0043-57020
280. Mariotti, V. M., Fatjó, J., Grau, M. A., & Vilanova, X. (2008). Apuntes de... Etología. Clinica Veterinaria De Pequenos Animales.
281. Markov, A., & Кramarov, S. (2018). Гастроінтестинальні симптоми при гострих нейроінфекціях у дітей. CHILD`S HEALTH. https://doi.org/10.22141/2224-0551.13.1.2018.127075
282. Marrie, R. A., & Palladino, R. (2023). Deciphering a Prodrome. Neurology. https://doi.org/10.1212/wnl.0000000000208070
283. Martin, A. D. S. (2001). Maladie de Huntington juvénile se présentant comme une épilepsie myoclonique progressive. Epilepsies.
284. Martynova, M. I., Smirnov, V. V., Sapelkina, L. V., Rodionova, E. M., & Pilyutik, V. F. (2000). Sochetanie sakharnogo diabeta u detey s drugimi endokrinnymi i somaticheskimi zabolevaniyami autoimmunnogo geneza. Diabetes Mellitus. https://doi.org/10.14341/2072-0351-6204
285. Martínez-Losada, C., Serrano‐López, J., Serrano‐López, J., Noguera, N. I., Garza, E. A. D. L., Piredda, L., Lavorgna, S., Consalvo, M. A. I., Ottone, T., Alfonso, V., Peinado, J. R., García‐Ortiz, M. V., Morales‐Ruíz, T., Jerez, A., Hurtado, A. M., Montesinos, P., Cervera, J., Such, E., Ibáñez, M., ... Sánchez‐García, J. (2018). Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with <i>NPM1</i> mutation is associated with phenotypic changes and worse outcomes. Haematologica. https://doi.org/10.3324/haematol.2018.188433
286. Marín, Á. G., Espejo, R. G., Molina, A. M., Salgado, E. G., Castillo, M. T., & Carrasco, J. M. P. (2021). Síndrome del lechón "arguellao".: Retorno al pasado: ¿qué hemos aprendido?. Suis.
287. Massa, J. L. P., & Martín-Álvarez, L. (2001). Trastornos del sueño en la primera infancia.. Psiquiatria.com.
288. Mayes, M. D. (2005). Genetic Features Of Scleroderma <i>Did You Get It From Your Parents? Can You Give It To Your Kids?</i>. https://doi.org/10.1093/oso/9780195169409.003.0005
289. Medeiros, C. C. M. (1998). Frequencia de alterações da função tireoideana, anticorpos antitireoide e tireomegalia em paciente com sindrome de Turner na faixa etaria de ate 20 anos. https://doi.org/10.47749/t/unicamp.1998.136001
290. Medina-Alva, M. D. P., Alvarado-Merino, R. Y., Ticona-Vildoso, M., & Valeriano-Valverde, E. (2019). Encefalopatía neonatal de origen inflamatorio-infeccioso. Reporte de caso y revisión de la literatura. Revista Peruana de Investigación Materno Perinatal. https://doi.org/10.33421/inmp.2019152
291. Mendes, H. N. T., Bezerra, I. B., Bezerra, B. M. O., Lima, F. E. D. S., Aquino-Cortez, A., Leite, A. K. R. D. M., & Guedes, R. F. D. M. (2022). DOENÇA DO TRATO URINÁRIO INFERIOR FELINO: EPIDEMIOLOGIA, SINAIS CLÍNICOS E DIAGNÓSTICO – REVISÃO INTEGRATIVA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-15-3-10
292. Mgaad, I., Bouziane, A., Narimane, S., Chami, I., Boujida, M. N., & Latib, R. (2016). Rate baladeuse associée à une anomalie de Neuhauser: à propos d’un cas. Pan African Medical Journal. https://doi.org/10.11604/pamj.2016.23.181.9200
293. Mibielli, M. A., & Torres, A. A. D. P. (2016). RASTREIO DA ESCOLIOSE EM PACIENTES PRÉ PUBERAL E PUBERAL.
294. Mishra, P., Muranjan, M., & Bharucha, B. A. (2000). Autosomal dominant ectrodactyly with sensorineural deafness. Clinical Dysmorphology. https://doi.org/10.1097/00019605-200009020-00009
295. Miyoshi, T., Murata, K., Tomizawa, T., Hiwatashi, S., Ishikawa, Y., & Yagi, S. (1979). Developmental Profile of the Speech Retarded Children. Practica Oto-Rhino-Laryngologica. https://doi.org/10.5631/jibirin.72.1033
296. Miziara, C. S. M. G., Serrano, V. A. G., Kok, F., & Marques‐Dias, M. J. (1988). Síndrome da criança espancada: aspectos neurológicos em 7 casos. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x1988000400003
297. Miziara, R. C., Wiezel, C. E. V., Júnior, G. A. D. S. P., & Simões, A. L. (2007). Freqüência Alélica e Ausência de Distúrbio de Segregação no Locus da Distrofia Miotônica em Indivíduos Normais. Revista Brasileira Multidisciplinar. https://doi.org/10.25061/2527-2675/rebram/2007.v11i1.242
298. Mondal, R., Sarkar, S., Aggarwal, V., & Sabui, T. (2012). Hyperimmunoglobulin E syndrome with Sjogren's syndrome in a child. South African Journal of Child Health. https://doi.org/10.7196/sajch.384
299. Monti, A. L. S., Schmitt, I. M., Siqueira, R. D. M., Matos, A. C. D. S., Coelho, C. N. D. N., Júnior, G. P. J., Sampaio, M. M., Machado, A. G. M., Sousa, B. M., Moraes, A. M., Sousa, L. M. F. D., & Silva, A. L. L. A. (2023). Amenorreia primária. International Seven Journal of Multidisciplinary. https://doi.org/10.56238/isevmjv2n4-009
300. Montoya-Reales, D. A., Lanza, C. G., & Almendares, J. D. (2021). Síndrome de trisomía 18: informe de un caso clínico. Revista Médica Hondureña. https://doi.org/10.5377/rmh.v88i1.11594
301. Morales, M. E. Q., Chalco, E. F. G., Sanchez, H. E. J., & Morales, P. F. F. (2018). Síndrome de Lynch: Caracterización genético clínica y epidemiología. Caso clínico. Revista de la Facultad de Ciencias Médicas de la Universidad de Cuenca.
302. Moreira-Silva, J. A., Narvaez-Castillo, B. A., & Gomez-Garcia, A. O. (2019). Temblor Mentoniano: Reporte De Un Caso Aislado. Revista Ecuatoriana de Neurologia.
303. Morton, S. U., Norris‐Brilliant, A., Cunningham, S. D., King, E., Goldmuntz, E., Brueckner, M., Miller, T. A., Gilovich, T., Liu, C., Adams, H., Bellinger, D. C., Cleveland, J. D., Cnota, J. F., Dale, A. M., Frommelt, M. A., Gelb, B. D., Grant, P. E., Goldberg, C. S., Huang, H., ... Newburger, J. W. (2023). Association of Potentially Damaging De Novo Gene Variants With Neurologic Outcomes in Congenital Heart Disease. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2022.53191
304. Mosquera, C. F. F., Souza, S. D. C., Souza, W. C. D., Nascimento, A. C., & Schlesener, A. H. (2018). AVALIAÇÃO DO EQUILÍBRIO ESTÁTICO EM CRIANÇAS COM DEFICIÊNCIA VISUAL (DV). Revista do Núcleo de Estudos e Pesquisas Interdisciplinares em Musicoterapia. https://doi.org/10.33871/2317417x.2018.9.1.2337
305. Mottadelli, G., Zambaiti, E., Guazzarotti, L., Virgone, C., & Gamba, P. (2020). Newborn with incarcerated inguinal hernia and complete androgen insensitivity syndrome. Journal of Pediatric Surgery Case Reports. https://doi.org/10.1016/j.epsc.2020.101476
306. Mélo, A. M., Mendes, B. S., Costa, R., Magri, L. V., Lara, L. A. D. S., & Mazzi‐Chaves, J. F. (2023). Atenção integral à população trans: panorama da atuação do cirurgião-dentista na atenção primária à saúde. BEPA Boletim Epidemiológico Paulista. https://doi.org/10.57148/bepa.2023.v.20.38289
307. Míssio, L., & Silva, A. B. (2019). LINFOMA NÃO-HODGKIN DUODENAL EM CRIANÇA DE SEIS ANOS: RELATO DE CASO. FAG JOURNAL OF HEALTH (FJH). https://doi.org/10.35984/fjh.v1i4.129
308. Møller, A. T., & Andersen, L. L. T. (2020). Graviditetsrelaterede neurologiske symptomer uden forud erkendt neurologisk sygdom. Research Portal Denmark.
309. Müller, A., & Zwaan, M. D. (2005). Anorexia nervosa und Bulimia nervosa. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-2005-865792
310. Nacamura, C. A. (2016). Perfil dos indivíduos com síndrome de down de um centro de especialidades odontológicas em um município de São Paulo.
311. Nanan, R., Wirbelauer, J., Werner, E., Schrod, L., & Speer, C. P. (2002). Angeborene Hyposplenie mit multiplen Begleitfehlbildungen: Variante des Ivemark-Syndroms. Klinische Pädiatrie. https://doi.org/10.1055/s-2002-33979
312. Nascimento, G. M. D., Nunes, C. S. A., Menegotto, P. F., Raskin, S., & Almeida, N. D. (2010). Cútis laxa: relato de caso. Anais Brasileiros de Dermatologia. https://doi.org/10.1590/s0365-05962010000500013
313. Nawawi, A. M. (2016). Perbedaan Antara Chronological age dan Dental age Menggunakan Metode Demirjian Pada Anak Sindrom Down.
314. Nelson, D. L., & Zoghbi, H. Y. (2006). Trinucleotide Repeat Expansions: Disorders. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0005528
315. Nelson, K. (2006). THYROID AND BRAIN DEVELOPMENT IN DEVELOPED AND DEVELOPING COUNTRIES. Neuropediatrics. https://doi.org/10.1055/s-2006-945780
316. Nordon, D. G., Guimarães, R. R., & Neto, V. S. D. (2010). HEMICOREIA, PARKINSON OU TRANSTORNO SOMATOFORME? O DIFÍCIL DIAGNÓSTICO DIFERENCIAL HEMICHOREA, PARKINSON'S DISEASE OR SOMATOFORM DISORDERS? A HARD DIFFERENTIAL DIAGNOSIS.
317. Nóbrega, P. R., Castro, M. A. A., Paiva, A. R. B. D., & Kok, F. (2022). Mystery solved after 23 years: M syndrome is <i>PIGT</i>‐associated multiple congenital anomalies‐hypotonia‐seizures syndrome 3. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.62977
318. Oliveira, J. A. D., Guimaraes, J. A., & Gonçalves, M. K. A. M. (2021). Trissomia do Cromossomo 21: Atenção Farmacêutica para Portadores de Cuidados Especiais / Trissomy of Chromosus 21: Pharmaceutical Care for Special Care Patients. Brazilian Journal of Development. https://doi.org/10.34117/bjdv7n11-516
319. Oliveira, K. D. S., & Pires, G. B. (2022). ACESSO A REDE DE ATENÇÃO EM SAÚDE MENTAL NO SISTEMA ÚNICO DE SAÚDE POR CRIANÇAS E ADOLESCENTES: UMA REVISÃO INTEGRATIVA. Anais do ... Seminário de Iniciação Científica/Anais Seminário de Iniciação Científica. https://doi.org/10.13102/semic.vi25.8489
320. Padrón, L., Paiva, G., Barcellos, M., Amim, J., Rezende-Filho, J., & Braga, A. (2021). Vídeo-histeroscopia no diagnóstico da gestação molar: mola hidatiforme parcial em idade gestacional precoce. Jornal Brasileiro de Ginecologia. https://doi.org/10.5327/jbg-0368-1416-20211311218
321. Palha, A. P., Romero, M. A., & Silva, A. F. (2006). [Hypochondriasis and Huntington's disease].. Actas Españolas de Psiquiatría.
322. Palmer, C. A., & Singh, M. (2008). Sjögren’s Syndrome and Its Implications for Diet and Nutrition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-403-2_14
323. Pap, S. Z. (2019). Nocne moczenie na tle nerwowym? To mit! Rodzicu, nie zwlekaj z wizytą u lekarza.
324. Park, K. H., Shin, D. J., & Kim, S. H. (2006). Central Core Disease : Clinical Characteristics of Family Members Manifested by Autosomal Dominant Pattern through Three Generations.
325. Pascasio, C. N. A. (2020). Hipoxia neonatal/síndrome de asfixia perinatal. Equinus: Medicina y cirugía equina.
326. Passos‐Bueno, M. R., & Splendore, A. (2001). Síndrome de Treacher Collins: aspectos clínicos, genéticos e moleculares. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v80i1p52-56
327. Pathania, V., & Sandhu, S. (2023). Endocrine disorders. CRC Press eBooks. https://doi.org/10.1201/9781351054225-58
328. Peeters, H., Crepel, A., Fryns, J. P., Devriendt, K., & Volder, A. D. (2008). Données génétiques dans les syndromes autistiques. A N A E-approche Neuropsychologique Des Apprentissages Chez L Enfant.
329. Peixoto, K. A., Menezes, J. P. B. D., Gomes, C. G. F., Botelho, Z. T., Cruz, C. S., Silva, L. D. L. R., Oliveira, P. R. P. F. D., Fagundes, M. K., Matos, I. M., Ribeiro, L. R. L., Andrade, B. G. D. O., Martins, P. H. L., Vargas, G. L., Filho, J. T. D. F., & Oliveira, N. D. (2023). Síndrome de Chediak-Higashi: um estudo de caso abordando características, diagnóstico e evolução clínica. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-257
330. Pereza, N., Zergollern-Čupak, L., & Peterlin, B. (2010). Klinička dismorfologija i razvojne anomalije Clinical dysmorphology and developmental anomalies.
331. Perkins, A. (2019). Toxic stress in children. Nursing Made Incredibly Easy!. https://doi.org/10.1097/01.nme.0000553087.55714.d4
332. Pfäffle, R., Sergeyev, E., Kieß, W., & Schöber, C. (2012). Sinn und Unsinn von Vorsorge untersuchungen. Kinder- und Jugendmedizin. https://doi.org/10.1055/s-0038-1629175
333. Pilar, A. G. M., Paola, L. L., Teresa, A. S., Noelia, H. A., Pablo, M. P., & Teresa, G. P. M. (2023). NEURAL TUBE DEFECTS IN THE NEWBORN. MONOGRAPHIC ARTICLE. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2023.81.44.001
334. Pinheiro, P., Peruzi, F. M., Parreira, A. A. D., Fernandes, B. M., Oliveira, A. J. C., Rodrigues, L. Q., Baía, J. L., Fonseca, F. R. E., Botelho, L. E. S., Franchi, L. M., Queiroz, T. C., Utim, G. G. M., & Fernandes, F. T. D. S. (2023). Síndrome de Ohtahara: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-170
335. Pires, H. A. F., Santos, L. R., Bonfim, B. R., Osolins, L. F., Aquino, I. P. D., Nemeth, M. E. R. F., Siqueira, Y. A., Carvalho, L. A. S. M. D., & Santos, T. A. N. (2022). Macrossomia fetal decorrente de diabetes na gestação e suas repercussões após o nascimento: aspectos etiopatogênicos, métodos diagnósticos e medidas preventivas. Brazilian Journal of Development. https://doi.org/10.34117/bjdv8n9-156
336. Plaisant, F., Meester, J.-P. D., Housiaux, J.-P., Brissart, R., & Thomazeau, É. (2009). Les troubles psychiatriques dans le syndrome de Klinefelter. Quels liens ?. L information psychiatrique. https://doi.org/10.1684/ipe.2009.0449
337. Plaisant, F., Meester, J.-P. D., Housiaux, J.-P., Brissart, R., & Thomazeau, É. (2009). Les troubles psychiatriques dans le syndrome de Klinefelter. Quels liens ?. L information psychiatrique. https://doi.org/10.3917/inpsy.8502.0187
338. PN, E., Hadinegoro, S. R., & Boediardja, S. A. (2016). Displasia Ektodermal Hipohidrotik. Sari Pediatri. https://doi.org/10.14238/sp5.3.2003.131-6
339. Poitou, C., Lubrano-Berthelier, C., & Clément, K. (2005). Les formes génétiques d’obésité associées à un hypogonadisme. Médecine Thérapeutique / médecine de la reproduction.
340. Poli, M., Clemente, M., Rubio, C., Capalbo, A., & Simón, C. (2020). The Patient Evaluation of the Future: Genetics, New Diagnostics, and Prediction Modeling. Cambridge University Press eBooks. https://doi.org/10.1017/9781108859486.003
341. Polyakova, S. (2010). Семейный анамнез детей с мутациями наследственного гемохроматоза.
342. Poonawalla, T., Xia, L., Patten, S., & Stratman, E. J. (2009). Clouston Syndrome and Eccrine Syringofibroadenomas. American Journal of Dermatopathology. https://doi.org/10.1097/dad.0b013e318186853e
343. Pophali, P. A., Klotz, J. K., Koklanaris, E., Savani, B. N., Chawla, K., Le, R., Wu, C. O., Barrett, J., & Battiwalla, M. (2012). Chronic GVHD and Age Are Not Associated with Bone Mineral Density Loss in the Second Decade Post-Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2011.12.202
344. Pratiwi, Q. (2022). Genetic Anticipation. KESANS International Journal of Health and Science. https://doi.org/10.54543/kesans.v1i4.40
345. Procedure, R. (2012). Premenopausal or postmenopausal female: high risk (includes personal history or family history or known or suspected genetic predisposition or elevated CA-125)..
346. Pugliesi, D. M. C., Santos, V. E. D., Panjwani, C. M. B. R. G., Araújo, L. D. C., Costa, P. J. C., & Amaral, G. C. D. (2019). Development of odontoma in the permanent dentition after intrusion of primary incisors: case report. Revista Científica do CRO-RJ. https://doi.org/10.29327/24816.4.2-8
347. Quaid, K. A., & Cushman, L. J. (2008). Genetic Counseling. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-405-6_15
348. Quante, A. S., & Goecke, T. O. (2010). Genetische Grundlagen des Marfan-Syndroms und verwandter Krankheitsbilder. Steinkopff eBooks. https://doi.org/10.1007/978-3-7985-1760-8_3
349. Quarrell, O. (2020). Facts and figures about Huntington’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198844389.003.0001
350. Rajadhyaksha, S., Pani, C., Varudkar, B. L., & Shah, K. (1993). Juvenile Huntington's disease.. PubMed.
351. Ramos, D., Reis, S., Cordinhã, C., Carmo, C. D., Gomes, C., & Correia, A. J. (2019). Acidose Tubular Renal Distal: Expressão Clínica Variável na Mesma Família. Acta Médica Portuguesa. https://doi.org/10.20344/amp.10758
352. Ramos, N. M., Silva, B. F., Miguez, R. D. A., Soares, S. C. M., Aires, M. M. G., Junqueira, M. M. F., Teixeira, B. R., Costa, G. C. D. P., Dalcom, P. H. S.-S. S. R., Tavares, I. B., Oedmann, A. F. B., Paula, C. M. D., Silva, B. C. D., & Leal, C. R. (2023). Síndrome de Stickler: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-179
353. Rangel, D. A. R., & Pinzón, J. D. G. (2016). Síndrome opsoclonus mioclonus paraneoplásico en pediatría: reporte de caso y revisión de la literatura. Acta neurológica colombiana. https://doi.org/10.22379/2422402230
354. Reis, C. A. S. (2020). Genetic hearing loss: GJB2 gene and a targeted-gene panel analysis.
355. Reuner, U., Sponholz, S., Hagen, M. V. D., Hahn, G., Reichmann, H., & Dinger, J. (2007). Ein Händedruck der Mütter - richtungweisend bei der Diagnostik des floppy infant: Diagnosestellung der myotonen Dystrophie und ihrer kongenitalen Form. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-970839
356. REZENDE, A. A., & Takahashi, K. (2008). AMELOGÊNESE IMPERFEITA E O PADRÃO HEREDITÁRIO: RELATO DE CASOS CLÍNICOS.. DENS. https://doi.org/10.5380/rd.v16i2.12165
357. Richter, J., Kracht, T., & Kattner, E. (2007). Neonatale nonketotische Hyperglyzinämie – Diagnose, Therapie und Verlauf bei einem komatösen Neugeborenen. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/s-2007-983255
358. Rincon, F. G. R. (2019). Evaluación del crecimiento en niños con hipotiroidismo congénito controlados, en seguimiento endocrinológico y del neurodesarrollo..
359. Rivera, V. R. (2012). Mutaciones de la conexina 26 y 30: correlación audiológica.
360. Rizzutti, S., Muszkat, M., & Vilanova, L. C. P. (2019). Epilepsias na Infância. Revista Neurociências. https://doi.org/10.34024/rnc.2000.v8.8939
361. Roberts, M. E., Jackson, S. A., Susswein, L. R., Zeinomar, N., Ma, X., Marshall, M. L., Stettner, A., Milewski, B., Xu, Z., Solomon, B. D., Terry, M. B., Hruska, K. S., Klein, R. T., & Chung, W. K. (2018). MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genetics in Medicine. https://doi.org/10.1038/gim.2017.254
362. Rodríguez, J. E. F.-B., Andino, A. B., Chiang, M. T., Pereira, A., Xavier, H. T., Herrera, J. A. C., Salado, C. B., Martínez, R. C., Guerra, J. B., Estévez, E. L., Martínes, D. S., & Padrón, M. D. J. P. (2005). La señal aterogénica temprana: estudio multinacional de 4 934 niños y jóvenes y 1 278 autopsias. Revista Cubana de Investigaciones Biomédicas.
363. Rohde, C., Thiele, A. G., & Beblo, S. (2019). Ernährungstherapie bei angeborenen Erkrankungen des Aminosäurestoffwechsels. Aktuelle Ernährungsmedizin. https://doi.org/10.1055/a-0839-0106
364. Romero, C., Dauber, A., & Cohen, L. E. (2013). Childhood Growth Hormone Deficiency and Hypopituitarism. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-395-4_1
365. Roos, R. A. (2009). The history of juvenile Huntington’s disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199236121.003.0003
366. Ropert, J. C., & Dworzak, P. (1998). Diagnostic des arthrogryposes chez le fœtus et le nouveau-né. MTP. Médecine thérapeutique pédiatrie.
367. Ros, N. G., Bailo, P., Tarancón, R. G., Martorell, L., & Álvarez, S. I. (2023). Tamaño de repeticiones CTG no aumentado en la transmisión de un padre con alelo expandido: falsa sospecha de fenómeno de contracción. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio. https://doi.org/10.1515/almed-2022-0120
368. Rosas, M., Cerisola, A., Martínez, F., Gontade, C., Medici, C., & González, G. (2016). Neurofibromatosis segmentaria: una entidad subdiagnosticada. Revista Uruguaya de Medicina Interna.
369. Roth, J. (2012). Juvenilní forma Huntingtonovy nemoci. Neurologie pro praxi.
370. Rowe, J. B., & Murley, A. G. (2023). Prodromal Disease and Mild Cognitive Impairment. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.077
371. Rudnik‐Schöneborn, S., Wyrwoll, M. J., Tüttelmann, F., Tóth, B., Pinggera, G., & Zschocke, J. (2023). Genetische Diagnostik bei ungewollt kinderlosen Paaren oder wiederholten Fehlgeburten. Gynäkologische Endokrinologie. https://doi.org/10.1007/s10304-022-00494-y
372. Rueda, N. E. (2006). Pueden los elementos endógenos y exógenos alterar el crecimiento y desarrollo y determinar una mordida abierta anterior severa; pueden ser susceptibles de tratamiento miofuncional las mordidas abiertas anteriores severas, en cualquier edad?.
373. Ryznychuk, М., & Pishak, V. P. (2019). Органы мочевыделительной системы: развитие, врожденная патология. KIDNEYS. https://doi.org/10.22141/2307-1257.8.2.2019.166665
374. Saadatagah, S., Naderian, M., Dikilitas, O., Hamed, M., Bangash, H., & Kullo, I. J. (2023). Polygenic Risk, Rare Variants, and Family History. JACC Advances. https://doi.org/10.1016/j.jacadv.2023.100567
375. Sabol, Z., Sabol, F., Šižgorić, M. K., Sabol, L. K., Klancir, S. B., Gjergja, Z., Juraški, R. G., Šojat, L. C., Krakar, G., Rešić, B., Sasso, A., Hafner, K., Oršolić, K., Marn, B., Dorešić, J. P., & Barišić, N. (2012). Neurofibromatoze: II. Kliničke upute za dijagnozu, liječenje i multidisciplinarno praćenje bolesnika s neurofibromatozom tip 2 i švanomatozom.
376. Sadeghi‐Nejad, A., Calenda, K., Schornagel, I. L., & Grand, R. J. (2005). Effect of Recombinant Growth Hormone Treatment on Children With Crohnʼs Disease and Short Stature: A Pilot Study. Inflammatory Bowel Diseases. https://doi.org/10.1097/01.mib.0000159321.58773.a6
377. Samoura, S., Koné, A., Sylla, I. S., Bah, M. B., Morlaye, S., Aly, S., Camara, A., Barry, I. S., Baldé, E. Y., Mariama, B., & Baldé, M. D. (2023). Right Heart Failure Indicative of Ebstein’s Disease in Adulthood about a Case. World Journal of Cardiovascular Diseases. https://doi.org/10.4236/wjcd.2023.139054
378. Sanchís, A., Taqua, B., Sabonet, L., Pérez-Moneo, P., Perez, M. L., & Balanzá, M. R. (2019). Diagnostico prenatal en Sindrome de Cornelia de Lange a propósito de 2 casos.
379. Sandarenu, W. W. I. P., Erathna, E. U. S., Alwis, H. K. K. I. D., Adicarum, D. R. S., & Arambepola, S. C. A. (2022). A case of excessive sexual drive or satyriasis. Sri Lanka Journal of Psychiatry. https://doi.org/10.4038/sljpsyc.v13i2.8366
380. Sanson, M. Z., BERRIEL, A. L. S., Maximiano, M. L. D. B., Rocha, R. D. S., & Viniegra, R. F. S. (2023). Desafios do cuidado da saúde da mulher com neurofibromatose tipo I: relato de caso. Jornal Brasileiro de Ginecologia. https://doi.org/10.5327/jbg-2965-3711-2023133s1020
381. Santos, A. C. R. D., Nakada, P. H., Araujo, M. G. D., Fernandes, B. M., Elias, C. D. C. D., Santos, C. R. D., Souza, G. M. D., Lacerda, J. V., Moreira, L. C., Costa, L. O. D., Pigozzi, L. M., & Cunha, L. V. D. (2021). Síndrome de Bruns-Garland: Relato de caso/ Bruns-Garland Syndrome: Case Report. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n5-279
382. Santos, M. V. S. B. D., Borges, V. L. C., Miura, C. T. P., Gomes, A. K., Romano, L. B. C., Brito, G. P., Maronezi, C., Miranda, G. M., Dourado, C. M., Damasceno, B. C., Soares, A. E. B. V., Lopes, Y. S., Batista, I. C. F., Carpaneda, J. D. M., & Figueiredo, M. C. R. (2023). Síndrome de Griscelli: relato de um caso pediátrico com desenvolvimento atípico e abordagem terapêutica e revisão da literatura. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-265
383. Santos, V. B., Garcia, J. V. B., Jordão, J. C. M., Capelli, L. B., Alves, T. B., Santos, S. C., Ferreira, S., Ataides, V. C., Polo, A. L., Paula, A. K. P. D., Santiago, A. M. M., Peres, C. H. R., Rezende, C. D. R., Camargo, J. H., Filho, M. C. G. G., Sousa, N. G. D., Shinyashiki, M. B., Maia, M. A., Paulino, O. L., ... Farinazzo, L. M. H. (2022). Síndrome de fraser. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv5n5-087
384. Sarmento, F., Braga, V. L., Fraiman, P., Rocha, F. A., Aragão, M. D. M., Pinho, R. S., & Masruha, M. R. (2023). Coreia oromandibular como manifestação inicial de Doença de Huntington juvenil. Revista Neurociências. https://doi.org/10.34024/rnc.2023.v31.14762
385. Sarzi, E., & Rötig, A. (2010). Instabilité du génome mitochondrial et pathologies associées. médecine/sciences. https://doi.org/10.1051/medsci/2010262171
386. Sarıcık, B., Yıldız, İ., & Koca, Y. S. (2018). İNKARSERE DEV MORGAGNİ HERNİSİ: OLGU SUNUMU. Bozok Tıp Dergisi. https://doi.org/10.16919/bozoktip.390440
387. Sautreuil, P., Mane, M., Missaoui, B., Bendaya, S., & Thoumie, P. (2016). Premiers chaussages orthétiques dans la maladie de Charcot-Marie-Tooth. médecine/sciences. https://doi.org/10.1051/medsci/201632s206
388. Saßmann, H., Bischofberger, B., Block, K., Neises, M., Noeres, D., Schmidt, C., Weike, U., & Geyer, S. (2005). Der Einfluss lebensverändernder Ereignisse beim Verlauf des Mammakarzinoms. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. https://doi.org/10.1055/s-2005-863548
389. Schmidtke, K. (2005). Argyrophilic Grains - Substrate of a New Dementing Illness?. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2005-870970
390. Schneider, S., González, M. M. G., Villalobos, P., Cabacas, A., Mayol, L., & Pérez, E. R. (2006). Ruminació com a causa de distròfia greu en un lactant. Pediatria catalana: butlletí de la Societat Catalana de Pediatria.
391. Schneider, S., Tadic, V., Kertelge, L., Brüggemann, N., Schmidt, A., Wisse, C., Drude, L., Vegt, J. V. D., Siebner, H., Lohmann, K., Buhmann, C., Hagenah, J., Klein, C., & Kasten, M. (2009). Beeinträchtigung der Geruchs- und Farbwahrnehmung bei genetischen und nicht genetischen Parkinson-Syndromen. Aktuelle Neurologie. https://doi.org/10.1055/s-0029-1238865
392. Shaarawy, A. O. E. (2019). Pediatric Bipolar Disorder: Diagnosis and Management. Research and Reviews on Healthcare Open Access Journal. https://doi.org/10.32474/rrhoaj.2019.03.000173
393. Sholl‐Franco, A., Wanderley, C. A. P., Príncipe, C. D. S. R., Pires, E. U., Ferreira, L. D. M., Ferreira, L. D. S., Santos, M. C. O. D., Pacheco, R. F., Bandeira, R. P., Silva, T. L. D. A. E., Crespi, T. F. A., & Menna, V. L. (2009). DESENVOLVIMENTO SEXUAL E COGNITIVO DAS PORTADORAS DA SÍNDROME DE TURNER. Ciências & Cognição.
394. Silva, A. C. P. D., Filho, N. R., Fernandez, S., Nardi, A. B. D., Neto, J. M. D. C., Pagani, D. D. S., Vicente, W. R. R., & Feliciano, M. A. R. (2016). PRINCIPAIS AFECÇÕES CONGÊNITAS DE CONCEPTOS FELINOS - REVISÃO. INVESTIGAÇÃO. https://doi.org/10.26843/investigacao.v15i9.1381
395. Silva, B. P., Souza, M. A. E., Castro, C. S. D., Carvalho, C. A. D., Rodrigues, B. P., Costa, M. M., Palheta, J. N. N., Barbosa, B. C., Machado, R. A., Issy, G. Z., Borelli, J. G., Munareto, M. L. B., & Mendonça, V. M. C. (2023). Doença de Gaucher: uma abordagem diagnóstica, evolução clínica e revisão. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n5-212
396. Silva, L. M. S., Santos, A. L. H. D., Santos, J. V. B. D., Barata, C. V., Gomes, A. C., Jesus, D. S. D., Oliveira, M. R., Santos, I. G. D., Neto, M. B. O., Silva, W. S. I. D., Jesus, J. V. D., & Lima, V. F. S. (2023). GIARDIA SP. E CRIPTOSPORIDIUM SP. EM ANIMAIS E SUA RELEVÂNCIA NA SAÚDE PÚBLICA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-28-3-8
397. Silva, T. F. P., Ribeiro, C. M., Lima, D. E. D. A. R., Melo, G. H. R., Rocha, G. F., Salazar, G. O., Ferreira, J., Roza, M. V. C., Laranjeira, R. M. P., & Melo, T. L. D. (2022). Escoliose idiopática do adolescente - classificação e manejo terapêutico / Adolescent idiopathic scoliosis - classification and therapeutic management. Brazilian Journal of Development. https://doi.org/10.34117/bjdv8n3-316
398. Silveira, A. L. (2013). Adenoma folicular associado ao hipotireoidismo congênito por defeito no gene da tireoperoxidase: relato de caso e revisão bibliográfica.
399. Siqueira, T. D. A. (2019). COMPREENDENDO OS SINTOMAS DA SÍNDROME DE KLINEFELTER..
400. Slotnick, C. F. (1988). Cognitive differences in classification tasks among autistic children. New Directions for Child and Adolescent Development. https://doi.org/10.1002/cd.23219883906
401. Soarès, C., & Toutain, S. (2009). Une cause d'échec scolaire.
402. Sobotka, S. A., Francis, A., & Msall, M. E. (2016). Developmental Outcomes of Prematurity: Autism Spectrum Disorder. NeoReviews. https://doi.org/10.1542/neo.17-6-e318
403. Sousa, C. M., & Humbert, S. (2013). Huntingtin: Here, There, Everywhere!. Journal of Huntington s Disease. https://doi.org/10.3233/jhd-130082
404. Spielman, R. S., & Ewens, W. J. (2006). Relatives‐based Test for Linkage Disequilibrium: The Transmission/Disequilibrium Test (TDT). Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0005429
405. Stavljenić-Rukavina, A., Kurjak, A., & Pooh, R. K. (2009). Molecular Genetics and Fetal Brain.
406. Stice, S. L. (2018). Modeling human pregnancy-associated developmental neurotoxicity in vitro using pluripotent stem cell-derived neurons and astrocytes. Journal of Pediatrics and Pediatric Medicine. https://doi.org/10.29245/2578-2940/2018/1.1114
407. Stipe, J., White, D. A., & Arsdale, E. V. (1979). Huntington's Disease. AJN American Journal of Nursing. https://doi.org/10.2307/3424618
408. Struck, M. (2000). Das Spektrum seelischer Störungen im Alter und Einteilung nach DSM-IV bzw. ICD-10. Deutscher Universitätsverlag eBooks. https://doi.org/10.1007/978-3-322-85178-9_4
409. Strupp, M., Zwergal, A., & Brandt, T. (2008). Episodische Ataxien. Aktuelle Neurologie. https://doi.org/10.1055/s-0028-1090085
410. Syrbe, S., Bertsche, A., Bernhard, M., Steiner, I., Biskup, S., & Merkenschlager, A. (2013). Benigne familiäre Neugeborenenkrämpfe bei einer Familie mit neuer Missense-Mutation im KCNQ3-Gen. Klinische Neurophysiologie. https://doi.org/10.1055/s-0033-1337317
411. Szita, B. (2016). A posztpartum depresszió evolúciós megközelítései. Magyar Pszichológiai Szemle. https://doi.org/10.1556/0016.2016.71.4.4
412. Tanet, A., & Ouss, L. (2016). Mal voir et ne pas le savoir : comment grandit-on avec un trouble neurovisuel ?. Contraste. https://doi.org/10.3917/cont.043.0113
413. Teixeira, P. N., Ferreira, J. M., Almeida, L. C., Barroso, V. D. D. M. P., & Mansur, O. M. F. D. C. (2022). Importância da identificação precoce dos riscos para autismo. Anais da Semana Científica da Faculdade de Medicina de Campos. https://doi.org/10.29184/anaisscfmc.v12022p4
414. Thiels, C., Stahl‐Pehe, A., Saft, C., Juckel, G., & Lücke, T. (2020). Zur Huntington-Erkrankung im Kindes- und Jugendalter – Erkrankung, klinische Präsentation und Probleme der Diagnostik. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-1082-6605
415. Tilghman, J. M., Ling, A. Y., Turner, T. N., Sosa, M. X., Krumm, N., Chatterjee, S., Kapoor, A., Coe, B. P., Nguyen, K.-D. H., Gupta, N., Gabriel, S., Eichler, E. E., Berrios, C., & Chakravarti, A. (2019). Molecular Genetic Anatomy and Risk Profile of Hirschsprung’s Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1706594
416. Tosti, A., & Piraccini, B. M. (2019). Nail Disorders. Harper's Textbook of Pediatric Dermatology. https://doi.org/10.1002/9781119142812.ch161
417. Trajano, C. C., Angelino, J. M. C., Leite, A. K. R. D. M., Aquino-Cortez, A., Bezerra, B. M. O., Lima, F. E. D. S., & Guedes, R. F. D. M. (2022). ENTERITE LINFOPLASMOCITÁRIA EM CÃES: UMA REVISÃO INTEGRATIVA. Editora In Vivo eBooks. https://doi.org/10.47242/978-65-87959-15-3-6
418. Unknown (2009). The role of genes in disease: beware of simplistic interpretations!. PubMed.
419. Unknown (2019). ADHS im Grundschulalter: Jüngere Schüler häufiger betroffen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-0890-9837
420. Unknown (2019). Genetic anticipation. Definitions. https://doi.org/10.32388/keqite
421. Unknown (2019). Heritability. Definitions. https://doi.org/10.32388/abzrvi
422. Unknown (2019). Trait. Definitions. https://doi.org/10.32388/276768
423. Vallat, J., & Funalot, B. (2010). La maladie de Charcot-Marie-Tooth. médecine/sciences. https://doi.org/10.1051/medsci/20102610842
424. Vallejo, D. V. C. (2020). Síndrome de Morquio, una afección infrecuente. REVISTA EUGENIO ESPEJO. https://doi.org/10.37135/ee.04.10.07
425. Varchetta, G., Palma, M., & Tanzillo, P. (2019). Linfoma di Hodgkin associato a sindrome nefrosica in età pediatrica: tecniche di studio in TC e PET/TC. Journal of Advanced Health Care. https://doi.org/10.36017/jahc1908-004
426. Vasconcellos, L. F., Leite, A. C., Cavalcanti, J. L. S., Moreira, D. M., Feijó, D., & Souza, C. F. M. D. (2007). Síndrome psicótica evoluindo com demência como manifestação clinica de deleção do DNA mitocondrial. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2007000100023
427. Vasconcelos, B. L. D., ALVES, R. T. D. L., & MEDEIROS, W. (2022). TRATAMENTO NEONATAL DE CRIANÇAS DIAGNOSTICADAS COM HIPOTIREOIDISMO CONGÊNITO. Anais do III Congresso Brasileiro de Ciências Biologicas. https://doi.org/10.51189/iii-conbracib/6370
428. Vashkevich, A., Tomasheva, A., Raznatovskiy, K., Gvenetadze, V. V., Reztsova, P., Kornisheva, V., Kotrekhova, L., Gulordava, M., & Klibson, S. (2022). Neurofibromatosis type 1: a clinical case. Russian Journal of Clinical Dermatology and Venereology. https://doi.org/10.17116/klinderma202221061758
429. Vecina, M. C., & Jiménez-Perianes, A. (2020). Aproximación teórica al síndrome de Munchausen por poderes.. Behavior & Law Journal. https://doi.org/10.47442/blj.v6.i1.77
430. Vega, B., & Patricia, L. (2019). Evaluación del Gen Igfals en una muestra de pacientes con talla baja idiopática en la ciudad de Bogotá.
431. Veiga, T. M., Cruz, T. R. D., Simão, R., Takatsu, E., Almeida, L. H. F., Ponte, I. M. F. T. D., Silva, M. A. D., Carvalho, C. P. B. D., Grings, M. S., Sousa, G. T. E. D., Santo, B. V. M. M. E., Bastos, E. H. S., Machado, B. A. P., Silva, J. A. S. D., Cunha, M. A. P., Cavalcante, R. L. D. C., Santos, D. R. D., Leite, D. S. L., Branco, K. M. L. R., ... Pereira, J. E. P. (2022). Os fatores determinantes e as complicações oriundas do crescimento fetal restrito. Brazilian Journal of Development. https://doi.org/10.34117/bjdv8n11-166
432. Verdezoto, G., Rugel, R., & Guzmán, A. A. (2012). Reporte de caso clínico: síndrome de Noonan. Medicina-buenos Aires.
433. Verster, R., & Merwe, L. M. V. D. (2005). The child molester : primary healthcare. Professional nursing today.
434. Vieira, M. W., Colturato, M. C., Mello, D. P. P. D., Rubez, A. C., Inoue, D. H. N., & Miguel, G. J. M. (2016). Síndrome de Noonan e suas complicações: um relato de caso. Revista da Faculdade de Ciências Médicas de Sorocaba.
435. Vieira, M. W., Pires, L. V. L., & Pereira, G. N. (2018). Síndrome de Shprintzen-­Goldberg: relato de dois casos e a importância da genética clínica. Revista da Faculdade de Ciências Médicas de Sorocaba.
436. Vignal, C., Uretsky, S., Fitoussi, S., Galy, A., Blouin, L., Girmens, J., Bidot, S., Thomasson, N., Bouquet, C., Valero, S., Meunier, S., Combal, J. P., Gilly, B., Katz, B., & Sahel, J. (2018). Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy. Ophthalmology. https://doi.org/10.1016/j.ophtha.2017.12.036
437. Vlad, R. M., Nicolaescu, D. I., & Albu, A. (2019). DEFICITUL IZOLAT DE HORMON DE CREŞTERE – CAUZĂ RARĂ, DAR TRATABILĂ DE HIPOSTATURĂ. Romanian Journal of Pediatrics. https://doi.org/10.37897/rjp.2019.2.16
438. Volio, I. C. (1998). Definición. Clasificación, etiología, diagnóstico y prevención del retardo mental. Acta Médica Costarricense. https://doi.org/10.51481/amc.v40i3.593
439. Volpato, S., Anrain, B. C., Lanzzarin, C., Bizzotto, J. F., Cachoeira, S. F., Frey, M. G., Déa, B. E. D., & Tomasi, P. Z. (2013). SINDROME DO X FRÁGIL: UM BREVE REFERENCIAL TEÓRICO. Ação Odonto.
440. Vygovskaya, L., & Gainutdinov, A. (2013). FEATURES OF NEUROLOGICAL DISORDERS IN PREMATURE CHILDREN IN THE RESIDUAL PERIOD OF DEVELOPMENT. NATIONAL JOURNAL OF NEUROLOGY. https://doi.org/10.61788/njn.v2i13.10
441. Waal, W. D. (1996). Influencing the extremes of growth : too tall - too small.
442. Wang, K., Das, A., Xiong, Z., Cao, K., & Hannenhalli, S. (2013). Identification of gene clusters with phenotype-dependent expression with application to normal and premature ageing. https://doi.org/10.1145/2506583.2506652
443. Warner, D. S., & Denborough, M. A. (2008). Malignant Hyperthermia. Anesthesiology. https://doi.org/10.1097/01.anes.0000296107.23210.dd
444. Weatherall, D. J. (2001). Genotype–Phenotype Relationships. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0003403
445. Weber, Y. G., Geiger, J., Kämpchen, K., Lindenberg, K., Landwehrmeyer, B., Sommer, C., & Lerche, H. (2005). Pathophysiologie der benignen familiären neonatalen Convulsionen (BFNC): immunhistochemische Analyse des KCNQ2 Kanals während der Entwicklung. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-919556
446. Wegoye, E., & Padayachy, L. (2013). Recognising congenital anomalies of the nervous system : more about... neurosurgery. CME: Your SA Journal of CPD.
447. Weiner, J., Tejura, H., Gibby, O. M., O’Leary, A., & Avasarala, S. K. (2005). Cushing's syndrome in pregnancy. Journal of Obstetrics and Gynaecology. https://doi.org/10.1080/01443610500303648
448. Weiss, K. M. (2006). Allele Spectrum of Human Genetic Disease. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0006033
449. Weller, R. O., Swash, M., McLellan, D. L., & Scholtz, C. L. (1983). Developmental and Neonatal Neuropathology. Clinical Neuropathology. https://doi.org/10.1007/978-1-4471-1335-5_11
450. Wennagel, D., Braz, B. Y., & Humbert, S. (2023). Traiter des défauts transitoires précoces des neurones dans un modèle murin de la maladie de Huntington empêche l’apparition de symptômes à l’âge adulte. médecine/sciences. https://doi.org/10.1051/medsci/2023036
451. Wenning, G. K., & Wolf, E. (2007). Autonome Störungen bei Parkinson. Nicht nur im fortgeschrittenen Stadium, sondern zum Teil zu Beginn oder vor Einsetzen der motorischen Symptome können nichtmotorische Störungen auftreten. focus neurogeriatrie. https://doi.org/10.1007/s12151-008-0065-2
452. Wiegand‐Grefe, S., & Lenz, A. (2019). Kinder und Jugendliche von Eltern mit narzisstischer Persönlichkeitsstörung. PiD - Psychotherapie im Dialog. https://doi.org/10.1055/a-0771-7201
453. Wildberger, H., & Flury-Cornelis, H. (1986). Konzentrische Gesichtsfeldeinschränkungen ungeklärter Genese. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/s-2008-1050684
454. Wilke, J. (1995). From a Survivor The Emotional Experience of Genetic Testing. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19950401-08
455. Wilson, G. N., & Cooley, W. C. (2006). Overgrowth syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511584381.017
456. Wohlrab, G., & Bölsterli, B. K. (2010). Von der benignen Rolando-Epilepsie (BRE)zum elektrophysiologischen Status im Schlaf (ESES):elektrophysiologische und klinische Evolution - Definition und EEG-Diagnostik. https://doi.org/10.5167/uzh-44448
457. Wong, M. D., Shapiro, M. F., Boscardin, W. J., & Ettner, S. L. (2002). Contribution of Major Diseases to Disparities in Mortality. New England Journal of Medicine. https://doi.org/10.1056/nejmsa012979
458. Woodward, S. (2009). The 4th National Neuroscience Nursing Conference, Regent's College, London, 12 May 2009: Poster presentations. British Journal of Neuroscience Nursing. https://doi.org/10.12968/bjnn.2009.5.7.43244
459. Yager, J. (1998). Anticipation and Imprinting in Psychiatric Conditions. Journal watch. https://doi.org/10.1056/jp199807010000013
460. Yasuda, C. S. (2023). Novas abordagens na investigação genético-molecular no hipogonadismo hipogonadotrófico congenito. https://doi.org/10.11606/t.5.2023.tde-26052023-151437
461. Yeo, K., Gupta, M., & Correll, C. U. (2021). Huntington’s Disease With Psychotic Features. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.20l02745
462. Zaman, A. (2008). HFE Mutations and Hereditary Hemochromatosis. Journal watch. https://doi.org/10.1056/jg200801170000001
463. Zanko, A., Yoon, G., Kramer, J., Guzijan, M., Lin, S., Foster-Barber, A., & Boxer, A. L. (2006). Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology. https://doi.org/10.1212/01.wnl.0000238390.86304.4e
464. Zanoteli, E., Peres, A. B. A., Oliveira, A. S. B., & Gabbai, A. A. (2019). Biologia molecular nas doenças do neurônio motor. Revista Neurociências. https://doi.org/10.34024/rnc.2004.v12.8883
465. Zapata, A. C. (2016). Clasificación y semiología de los trastornos del lenguaje en el niño. Revista EDUCA UMCH. https://doi.org/10.35756/educaumch.201608.39
466. Zapata, A. C. (2016). CLASIFICACIÓN Y SEMIOLOGÍA DE LOS TRASTORNOS DEL LENGUAJE EN EL NIÑO. Revista EDUCA UMCH. https://doi.org/10.35756/educaumch.v8i0.39
467. Zbaida, R. A. (2019). Hirschsprung Disease: A Review. Academic Journal of Pediatrics & Neonatology. https://doi.org/10.19080/ajpn.2019.08.555786
468. Zeanah, C. H. (1996). Beyond insecurity: A reconceptualization of attachment disorders in infancy.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.64.1.42
469. Zeanah, C. H. (1996). Beyond insecurity: A reconceptualization of attachment disorders of infancy.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037/0022-006x.64.1.42
470. Zimmet, P., Walder, K., & Collier, G. R. (2006). Diabetes: Genetics. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0005561
471. Ávila, D. F. D., Silva, C. B., Castro, J. R. D., Rodrigues, C. G., Braga, P. F. D. S., Mundim, E. D., Mendonça, C. S., & Mundim, A. V. (2009). Anomalia de Pelger-Hüet em cadela – relato de caso. Veterinária Notícias      Veterinary News.
472. Çavuşoğlu, Ç., Demirkol, M. E., & Tamam, L. (2019). Attention Deficit Hyperactivity Disorder in the Elderly. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. https://doi.org/10.18863/pgy.548052
473. ÖZALKAYA, E., Akdağ, A., Papatya, E. D., & Topçuoğlu, S. (2016). Neonatal kolestaz ile başvuran, konjenital hipofiz hormon eksikliği tanılı yenidoğan olgusu. Zeynep Kamil Tıp Bülteni. https://doi.org/10.16948/zktipb.266110
474. ÖZDEMİR, K., Köksoy, A. Y., & DİNÇEL, N. T. (2016). Approach to Familial Hematuric Diseases: Review. Turkiye Klinikleri Journal of Pediatrics. https://doi.org/10.5336/pediatr.2016-51679
475. Özer, E., Yıldırım, A., Enginyurt, Ö., & Yılmaz, R. (2012). İkili Ölüm: Olgu Sunumu. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi.
476. Šumnı́k, Z., Koloušková, S., Wales, J. K., Komárek, V., & Cinek, O. (2007). Sulphonylurea treatment does not improve psychomotor development in children with <i>KCNJ11</i> mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome). Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2007.02228.x